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gram-positive and gram-negative organisms may be responsible . . ."1 
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antibiotics, its highly effective action ensures quick clinical response.
1Gunton R. W. "A  Current Evaluation of Newer Antibiotics" Canadian Family Physician.^ 
P. 23, May, 1968.
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Precautions and Contraindications Cephaloridine should not be used in pregnant women unless, in the judgment of the 
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and cephaloridine levels should be monitored.
Ceporan is inactive against protozoa, helminths, and fungi, including Candida albicans. Although Proteus mirabilis, the * 
commonest Proteus species, is sensitive to Ceporan, the antibiotic is generally not active against other Proteus species. 
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isms which develop resistance to other antibiotics retain their sensitivity to Ceporan; thus, Ceporan is usually active against* 
the penicillin-resistant staphylococci.
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ideal working conditions for 
the surgical staff —  a dry sur­
gical field —  rapid reversibility 
—  nonflammability. Twenty-five 
million operative procedures 
evidence the high regard sur­
geons have for this "most im­
portant general anesthetic to 
be introduced during the past 
20 years.'" Surgeons also ap­
preciate the many complimen­
tary services provided with 
FLUOTHANE— such as Ayerst's 
Film, Tape, and Reprint Library, 
scientific brochures and com­
plete worldwide bibliography.
purchasing 
team's choice
Hospital adm inistrators and 
hospital pharmacists choose 
FLUOTHANE because over the 
years they have come to respect 
the consistent quality, compet­
itive price and extra services 
that are a part of this Ayerst 
product. The purchasing team 
appreciates such services as the 
availability of two sizes, anal­
ysis of halothane samples, auto­
matic vaporizer maintenance 
service, vaporizer loan service 
and assistance in purchasing 
vaporizers.
anesthetist s 
choice
- ' SA n e s th e tis ts  f i r s t  choose 
FLUOTHANE because of the 
consistently good resultsachiev- 
ed over its 14 year h istory. 
Rapid, smooth induction. Ease 1 
of maintenance. Rapid arousal 
and recovery. Nonflammability. :i 
Predictability and reliability at­
tested to by over 1250 publi- *?: 
cations around the world. An­
esthetists also appreciate such 
complimentary services as anal­
ysis of halothane samples, auto­
matic vaporizer service, and 
Ayerst's Film, Tape and Re­
print Library.
T .M . Reg'd. 
L r i i j  864/71
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QUILL ON SCALPEL This section
provides a medium through which Canadian 
surgeons can declare themselves, briefly and in­
formally, on the day-to-day affairs of surgery.
MECHANICS OF URETERAL 
DILATATION
Treatment of abnormalities that result 
in ureteral dilatation is often based on the 
static picture obtained from the intra­
venous urogram. In an article elsewhere 
in this issue (page 4), Tanagho has shown 
experimentally that ureteral structure and function change with different degrees of 
dilatation and also that these changes vary 
in different segments. Thus, effective treat­
ment must be based on a knowledge of these differences.
Appreciation of variations in the ureteral 
wall is particularly important in surgical 
repair of the ureterovesical junction, where 
techniques that discard the abnormal termi­nal segment are preferable to those that re­
tain it. Tailoring procedures reduce the di­
ameter of the ureter but will not improve 
flow if the peristaltic function of the wall 
has already been destroyed by overstretch­
ing or infection. Revision of the ureteral 
orifices in the “prune-belly” syndrome will 
not decrease ureteral dilatation and stasis 
because the orifices are not obstructive; 
the defect that allows dilatation is in the 
ureteral wall itself.
Again, fundamental observations in the 
laboratory have led to more rational clini­
cal procedures.
F rank H inman, Jr .
University of California School of Medicine,San Francisco, Calif., U.S.A.
SELECTION FOR LUNG CANCER 
SURGERY
Lung cancer is now the most common 
cancer in the adult male and is rapidly increasing in frequency in the female 
population. The long-term results of treat­
ment are still poor, with a 13% five-year
survival rate, but it has now become 
possible to select the patients for operation 
in such a way that of those operated upon, 
96% are resectable with almost 40% five- 
year survival. By such selection, only those 
with a good chance of cure are operated 
upon; those patients refused operation are 
rejected on the basis of a tissue diagnosis 
of inoperability. This major change in the 
practice of thoracic surgery has taken place in the last 10 years.
Selection for surgery is based upon 
history and physical examination, radio- 
logic examination, liver function studies, 
pulmonary and cardiac function and, to a 
large extent, upon bronchoscopy and medi­
astinoscopy.
On history alone, the physician may 
strongly suspect metastatic spread of 
bronchogenic carcinoma to brain, bones, 
liver, skin or esophagus. Further investiga­
tion of these sites may confirm or deny 
the presence of carcinoma.
Local spread may be noted on physical 
examination, with the findings of pupil 
changes in the eye or anhydrosis of the 
face, nodal spread in the neck or superior 
vena caval obstruction.
More specific investigation of the lung 
lesion can be carried out radiologically. 
Standard chest films are the most useful 
examination in locating the lesion and de­
termining potential areas of local spread. 
Tomography is of value in defining the lesion, looking for calcification and deter­
mining local bone spread. Bronchograms 
are not often used but have a place in con­
firming peripheral bronchial obstruction if the diagnosis is in doubt. Pulmonary angio­graphy gives accurate assessment of pul­monary arterial involvement in centrally 
placed tumours, and is also useful in de­
termining minor degrees of superior vena caval obstruction. Barium swallow is used
2 THE CANADIAN JOURNAL OF SURGERY Vol. 15
to determine esophageal spread of the dis­
ease and this information can be further 
supplemented by esophagoscopy and medi­
astinoscopy.
Routine laboratory studies should in­
clude an assessment of liver function, en­
zyme determinations like alkaline phos­
phatase, SCOT and BSP studies. When in 
doubt, liver needle biopsy may obtain a 
tissue diagnosis of liver spread. Liver 
scans are inaccurate and give too many 
false positive results to be of much value. 
If liver metastases cannot be excluded, a 
small laparotomy with inspection and 
biopsy of suspicious lesions is sometimes 
the only effective method of excluding 
metastatic disease.
Bronchoscopy and mediastinoscopy are 
the two most accurate methods of assess­
ing local operability of the tumour. Bron­
choscopy allows biopsy and tissue diag­
nosis of main-stem bronchial carcinoma. 
Bronchoscopy alone may show an inoper­
able situation if the trachea or tracheal 
carina are involved by tumour.
Mediastinoscopy gives access to the 
lymph nodes at both tracheobronchial 
angles, in the anterior subcarina and in the 
subinnominate space. Biopsy of these 
nodes will allow an accurate tissue diag­
nosis of the spread of the disease. At medi­
astinoscopy, the exact location of nodes 
should be recorded because location is of 
prime importance in determining opera­
bility.
Mediastinoscopy is critical in determin­
ing operability and, hence, should be done 
by the surgeon who is going to do the 
resection. Inaccurate mediastinoscopic 
findings may result in unnecessary thorac­
otomy and, furthermore, the operation of 
mediastinoscopy is difficult to repeat and 
is less accurate on the second occasion.
Most patients who have mediastinal 
lymph-node involvement are considered in­
operable. At present in the Division of 
Thoracic Surgery, Toronto General Hos­
pital, we are assessing the results of re­
section after 3500 rads of radiation given 
over three weeks in a small group of pa­
tients with favourable malignancy and 
small nodal metastases at the tracheo­
bronchial or in the anterior subcarinal 
lymph nodes. It is too early to assess fully
the results of this approach but early 
results are encouraging.
Anterior mediastinoscopy, done through 
a two-inch anterior incision in the second 
interspace, allows the surgeon to assess 
further the local spread of the disease. This 
procedure is of particular value in left 
upper lobe carcinoma, which character­
istically spreads to the anterior medi­
astinum and may be missed by the stand­
ard mediastinal approach.
As a routine, all of our patients are 
assessed by history, physical examination, 
laboratory studies, bronchoscopy and medi­
astinoscopy. Additional studies are used 
only as indicated, to clarify particular 
tumour invasions. This investigation de­
termines operability in terms of tumour 
spread, but does not determine the pa­
tient’s ability to withstand operation.
Age is no longer a contraindication to 
lung surgery if the patient is mentally 
and physically healthy. Lobectomy in a 
healthy person can be tolerated even in 
80-year-old patients. Pneumonectomy, 
especially right pneumonectomy, places a 
greater strain on cardiac function and 
should be done on patients over the age of 
70 years only after careful assessment.
Heart disease is not often the major 
contraindication to surgery for lung can­
cer, but recent myocardial infarct (under 
three months), severe angina or advanced 
cardiac failure are contraindications.
Impaired pulmonary function is much 
less of a contraindication than we once 
believed. The surgeon always estimates the 
volume of true functioning lung he is re­
moving in contrast to the total mass of 
lung removed. Severe respiratory distress 
is not a contraindication if the lung being 
excised is already totally destroyed and, 
indeed, many such distressed patients im­
prove markedly when an obstructed in­
fected lung is removed. However, it is 
difficult to make precise correlation be­
tween pulmonary function and operability. 
The surgeon must exercise good judgment 
after assessing the patient’s past pulmonary 
function, his present exercise tolerance, 
blood gases and pulmonary function 
studies. Specific lobar and whole-lung 
function can be investigated by broncho- 
spirometry, angiography and zenon scan-
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ning, to determine the actual function of the portion of lung to be removed and the 
anticipated residual lung function.
Careful preoperative physiotherapy and 
antibiotic therapy may greatly improve the patient’s exercise tolerance and may 
control respiratory tract infection both before and after operation.
In our experience, accurate assessment 
of resectability and careful selection of pa­
tients for lung cancer surgery have steadily 
improved the five-year survival rate in this 
disease. In addition, assessment of pul­
monary and cardiac function and careful 
preoperative and postoperative manage­
ment have steadily lowered the postopera­
tive mortality rate.
R. D. Henderson
Toronto General Hospital,Toronto, Ont.
REVIEWS OF EXPERIENCE
Special advantages accrue to the writer of scientific reviews. First, the acceptance 
of this responsibility forces him to sort the 
lumber in his intellectual attic and evalu­ate anew the basic concepts in his chosen 
field. Even if his paper is not published 
or, if published, is read only by a few of 
his colleagues, he will still gain much by 
his effort. Second, a good review article 
makes a real contribution to the education 
of a physician’s peers, the students of his 
time and to his posterity. Recently, when 
discussing this subject, R. Ian MacDonald, 
a distinguished clinician and teacher, 
drew attention to the central place in 
medical education of such reviews as 
F. R. M. Walshe’s “Intracranial Tumours: 
A Critical Review”.1 Every teacher can 
cite one, several or many such papers that 
have been milestones on his road to pro­fessional competence.
However, as any editor will testify, re­
view articles are hard to come by. That we have survived till now without provid­ing a reliable mechanism of insuring peri­odic reviews of current progress does not make this problem any less important. Furthermore, although our system provides 
funds to promote the collection of data on a large scale, it provides little to support the analysis of the same data. In
addition, we forget at times that the indi­vidual who writes review articles must bring to this task extensive communica­tion skills. He must combine criticism, 
analysis and synthesis—scholarly attributes of a high order. For this reason, the scien­
tific community cannot or, at least, should not delegate the writing of these reviews 
to the newcomer, to the youngest member 
of the team. Departmental chairmen know 
which of their staff have reached a point 
where they can prepare a review: all that 
remains is for them to pursue the matter 
(and the author) to a successful conclusion.
As C. G. Roland, Chairman, Department 
of Biomedical Communications at the Mayo 
Clinic, points out “science in an unbeliev­
ably productive era for all its components, 
continues to condone the appallingly in­adequate style of communication which 
debases so many of our journals and books. As a consequence, the need for 
communication increases at an unprece­
dented rate, while the oral and written literacy of newly trained professionals seems to decrease each year.”2 However, 
a much more serious malady seems to underlie our communications difficulties— 
the disease of indifference. Bentley Glass 
has remarked that scientists overemphasize 
the importance of laboratory or field tech­nique and underemphasize or underesti­
mate the importance of the communica­
tion of ideas. In addition, many scientists 
seem not to care about expressing them­
selves clearly, and, as long as otherwise re­
putable journals continue to publish badly 
presented articles, there is no pressure on 
the author to improve. The author need 
not go through the painful business of 
struggling to communicate well when he 
can pass the burden on to his readers. As 
Roland reminds us “The equation makes 
scant sense, and the outcome may be serious indeed. If one part of science—the preparation of the ‘literature’—can be done 
shoddily without penalty, will the same attitude of indifference not come to affect 
the rest of the scientific effort?”
J. O. Godden
R efe r e n c e s
1. W a lsh e  FR: Intracranial tumours: criticalreview. Q ] Med 24: 587, 19312. R o land  CG: Personal view. Br Med J 3: 301,1971
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R E V I E W  A R T I C L E
MECHANICS OF URETERAL DILATATION*
EMIL A. TANAGHO, M.D., M.Ch., San Francisco, Calif., U.S.A.
The dilated ureter is a major problem in 
urologic surgery. Although the mechanism 
of dilatation in the presence of organic 
obstruction is clearly understood, its 
mechanism in several other pathologic 
situations is either controversial or inade­
quately explained.
Observations accumulated from experi­
mental and clinical studies on normal and 
pathologic ureters are clarifying the etiol­
ogy and mechanism of specific types of 
ureteral dilatation. Herein I will attempt to 
tie these observations together, relating 
embryologic and myogenic features of the 
ureter to the etiology and pathology of 
dilatation.
dorsomedial aspect of this cellular pro­liferation. The outpouching then grows 
cranially to meet and unite with the meta- 
nephric cap; at the same time the common 
nephric duct is absorbed into the uro­
genital sinus and the ureteral bud gains an 
independent opening into the urogenital 
sinus.
Condensation of loose mesenchyme 
around the ureteral bud marks the start of 
its muscularization and can usually be 
noted as early as the 26-mm. stage (late in 
the eighth week).1-2 Initially, the young 
mesenchymal cells have a circular orienta­
tion around the ureteral bud. Later, longi­
tudinally oriented fibres are seen. There is,
Fig. 1.—Longitudinal section through the intravesical ureter showing the purely longitudinal orientation of ureteral muscles. Note the meeting of the ureteral roof and floor fibres at the level of the ureteral orifice as ureteral musculature continues to form the superficial trigone (Trichrome stain X 25).
E m bbyologic  F eatures
The ureter develops as an outgrowth of 
the mesonephric duct at the end of the fourth week of embryonic life. Close to its caudal end, where it bends to open into the cloaca, the mesonephric duct develops a localized thickening by cellular prolifera­tion around its circumference. The ureteral bud first appears as an outpouching of the
"From the Division of Urology, University of Cali­fornia School of Medicine, San Francisco, Calif.
however, no layering of this mesenchymal tissue. Differentiation of these mesenchy­
mal cells into muscle fibres determines the ureteral muscle coat. Hypothetically, if the developing ureter elongates, the circularly oriented mesenchymal cells (which at this 
phase are differentiating into muscle fibres) will assume an increasingly longitudinal orientation. If the ureter mainly widens, the muscle fibres differentiating from these mesenchymal cells will assume a more ac­centuated circular orientation. There is ex-
*
V
*
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Fig. 2.—Longitudinal section of the pelvic wall, 
showing an abundance of circularly oriented fibres 
(Trichrome stain X 7).
perimental evidence that intrauterine sur­
gical intervention at various phases in the 
development of the fetal ureter has in­
duced and/or prevented these anatomic 
changes.3
Normally, the ureter overall grows more 
in length than in breadth, thereby produc­
ing an almost equal mixture of fibre orien­
tation.4'7 However, rate and direction of 
growth are not uniform and at both ends 
the ureter undergoes different specific 
changes (Fig. 1). The terminal part of the 
ureter (the intravesical ureter) has a purely 
longitudinal muscle arrangement, whereas 
the proximal part (the renal pelvis) has a
Fig. 3.—T 1 e effect of widening and lengthening 
at the urf eropelvic junction, resulting in a 
funnel-shap d appearance.
preponderance of circularly oriented fibres 
(Fig. 2). Widening of the cranial end of 
the ureteral bud, if associated with little or 
no longitudinal stretching at this level, 
produces a sharp transition between a wide 
box-shaped, pelvis and a normal-calibre 
ureter.8 However, if the widening is as­
sociated with some longitudinal stretching, 
the outcome will be the commonly en­
countered funnel-shaped ureteropelvic 
junction, which is definitely more desirable 
hydrodynamically (Fig. 3 ).
M yogen ic  Features
The ureter has only one muscle coat in 
contrast to the layering seen in other 
smooth muscle tubes. As a result of the 
lengthening, stretching, and rotation of the 
developing ureteral bud, each ureteral 
muscle bundle assumes an irregular helical 
orientation. The combination of several 
helical bundles results in the commonly 
seen ureteral muscle arrangement where 
fibres run in all directions (Fig. 4 ) .4-7 In 
the terminal ureter, however, the helical 
loops open widely, and the fibres assume a 
purely longitudinal orientation (Fig. 1). 
The terminal ureter loses its lumen at the 
ureteral orifice and continues uninterrupted 
into the trigone.9 This arrangement offers 
an efficient adaptable sphincteric mecha-
6 THE CANADIAN JOURNAL OF SURGERY Vol. 15
nism at the ureterovesical junction that 
guards against regurgitation of urine from 
the bladder and at the same time gives 
minimal resistance to the flow of urine 
from the ureter to the bladder.
Fig. 5.—Intravenous pyelogram of a 7-year-old 
boy with diabetes insipidus. Note the wider 
ureteral lumen, with no evidence of stasis.
E tiology
Factors leading to ureteral dilatation 
may be physiologic or pathologic.
Physiologic factors are intermittent; when 
the predisposing factor is relieved, the 
ureter regains its normal calibre. Usually 
there is only ureteral dilatation with no 
lengthening.
Diuresis is a common physiologic factor 
and is encountered frequently because of 
the increasing use of infusion pyelograms 
and angiograms. The ureter is capable of 
transporting a limited volume per unit of 
time.10 This volume is more than three or 
four times the average normal urinary out­
put. Within this volume range, the ureter 
will vary its calibre and diameter by using 
its reserve capacity—dilating without 
lengthening.11 The ureteral segment that 
limits emptying ability is the narrowest 
least-stretchable segment and the one with 
the highest resistance—the intravesical 
ureter. If urine output exceeds ureteral 
emptying ability, pathologic stretching oc­
curs. Urine output normally is not constant, 
and the ureter is able to handle normal 
diurnal variations in urinary output as well 
as phases of physiologic diuresis.12’ 13 How­
ever, in cases of pathologic sustained 
diuresis (as in diabetes insipidus), the 
ureter may give way and remain dilated14 
(Fig. 5 ), or in a sense adjust itself to the
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I N T R A V E S I C A L  P R E S S U R E
_________________________
Fig. 6.—Simultaneous recording of intravesical pressure and resistance to flow through the intra­
vesical ureter during bladder filling and voiding. Note the minimal rise in intravesical pressure with 
filling, yet the marked rise in resistance to flow. At the end of filling, resistance to flow was about 
75 mm. Hg although intravesical pressure was only 25 mm. Hg. There was an even sharper rise 
(over 150 mm. Hg) during voiding although intravesical pressure was only 40 mm. Hg. (Reproduced by 
permission from Tanagho EA, Hutch JA, Meyers FH, et al: Primary vesicoureteral reflux: experimental 
studies of its etiology. J  Urol 93: 165, 1965.)
added load by constantly filling and 
stretching, thus adding to its reserve capac­
ity. The ureter adapts itself to this over­
load, and in most instances the degree of 
ureteral dilatation, although significant, is 
not progressive over the years. During 
diuresis, although stasis may be interpreted 
from the pyelographic appearance, the 
ureter is constantly transporting its con­
tents at a maximal flow rate and is filling 
as fast as it is emptying.
In a normal voiding cycle, progressive 
bladder filling and distension cause a pro­
gressive increase in the resistance of the 
intravesical ureter, leading to ureteral 
stasis and dilatation15 which will be re­
lieved immediately after voiding and 
bladder emptying. During bladder disten­
sion, the resistance to flow in the intra­
vesical ureter can be as high as 60 to 80 
mm. Hg, which is far beyond ureteral 
contractility (Fig. 6). The obstructing 
mechanism is not the intravesical pressure 
which is usually within the range of 10 to 
20 mm. Hg during bladder filling. Rather 
the stretched trigone firmly occludes the 
intravesical ureter and thus increases its 
resistance to flow.15
Other physiologic factors in ureteral di­
latation are hormonal effects, seen in 
pregnant women16’ 17 or in those using 
contraceptive pills.18 The mechanism is 
probably relative hypotonia with resultant
ureteral dilatation, enormously increasing 
reserve capacity with minimal ureteral 
lengthening.
Pathologic factors leading to ureteral di­
latation are numerous. Impacted stones,
Fig. 7.—Voiding cystourethrogram showing bi­
lateral reflux in markedly dilated tortuous ureters.
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tumours, intrinsic ureteral stricture, and 
ureteral compression by a nearby mass are 
clearly mechanical encroachments on the 
ureteral lumen that impede transport and 
result in ureteral dilatation and length­
ening. However, in other instances, the 
mechanics of obstruction are not clear.
In ureteral dilatation associated with 
vesicoureteral reflux (Fig. 7) there is no 
organic narrowing in the ureter and 
drainage at first is perfect. The mechanics 
of dilatation are primarily: (1) the ureter 
is overstretched repeatedly to a degree that 
depends on the volume of refluxing urine; 
(2) the ureteral wall is subjected to higher
bearing on the ability of such a ureter to 
recover.
Ureteral dilatation commonly develops 
also as a result of infravesical obstruction 
or neurogenic bladder dysfunction in spite 
of the presence of a competent uretero­
vesical junction. In these instances, resting 
intravesical pressures are normal20 yet 
voiding pressures are high. Since the 
ureterovesical junction is competent, these 
pressures are not transmitted to the upper 
urinary tract. Detrusor thickening was 
partly blamed for strangulation of the 
intravesical ureter and the ureteral obstruc­
tion. Our studies, however, implicate tri­
Fig. 8.—Intravenous pyelogram (IVP) of a patient with obstructive benign prostatic hyperplasia. 
(A ) Two-hour film showing marked bilateral hydronephrosis with seriously impaired function on the 
left side. (B) Intravenous pyelogram 10 days after catheter drainage showing marked regression in the 
degree of ureteral dilatation with improvement in ureteral drainage and kidney function. (C) Cysto- 
gram showing no reflux. (D) Intravenous pyelogram two weeks later after transurethral resection show­
ing improvement and regression of the dilatation.
pressures—both resting intravesical pres­
sure and the much higher voiding pressure 
—and usually progressively gives way and 
dilates; (3 ) the ureter must transport an 
increased volume equal to the urine output 
plus the refluxing urine; (4) an intrinsic 
ureteral feature aggravates these three 
other factors and leads to further ureteral 
dilatation and tortuosity: the refluxing 
ureter, especially in severe cases, is usually 
congenitally muscularly deficient to a 
variable degree,19 which limits its ability 
to resist higher pressures and increased 
volume. The ureter cannot respond as a 
normal ureter by showing hypertrophy and 
by developing more muscle mass and tone 
to counteract these adverse hydrodynamic 
changes. This same phenomenon has a
gonal hypertrophy ( always present in these 
instances) as the primary factor increasing 
resistance.21 Stretching of the hyper­
trophied trigone by the residual urine 
that is commonly present aggravates this 
obstructive mechanism even more. Simple 
bladder drainage will relieve this stretch­
ing and minimize the resistance at the 
intravesical ureter (Figs. 8 and 9). Tri­
gonal irritation and spasm from pro­
longed use of catheters or suprapubic tubes 
can lead to a similar obstructive phenome­
non.15' 20
A puzzling entity of ureteral dilata­
tion is the obstruction encountered in the 
absence of any of the previously mentioned 
causes. The terminal ureter is the com­
monest site of such an obstructive phe-
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Fig. 9.—(A) Intravenous pyelogram o f a patient with neurogenic bladder with large residual and 
showing marked bilateral dilatation. (B) Intravenous pyelogram 24 hours after catheter drainage. Note 
the regression in the degree of ureteral dilatation because of the release of trigonal stretch.
nomenon, with dilatation of the pelvic 
ureteral segment that may extend to in­
clude the entire upper urinary system ( Fig. 
10). Several etiologic factors have been
incriminated, e.g. aperistaltic segment, 
achalasia o f the ureter, similar to Hirsch­
sprung’s disease with lack of ganglion cells 
and persistence of Schwalla’s mem-
Fig. 10.—(A) Delayed IVP of a patient with functional ureteral obstruction with massive hydro­
ureter and hydronephrosis. (B) Surgical exploration showing the dilated ureter tapering to normal juxta- 
vesical ureter. (C) Intravenous pyelogram four months after ureteral tailoring and reimplantation. (Repro­
duced by permission from Tanagho EA, Smith DR, Guthrie TH: Pathophysiology of functional ureteral 
obstruction. J Urol 104: 73, 1970.)
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Fig. 11.—(A) Cross-section of intravesical ureter shown in Fig. 10. Note the normal purely 
longitudinal muscular arrangement. (B) Cross-section of the functionally obstructive juxtavesical ureter 
with almost purely circular muscular orientation (Trichrome stain X 5 ). (Reproduced by permission 
from Tanagho EA, Smith DR, Guthrie TH: Pathophysiology of functional ureteral obstruction. 
/ Urol 104: 73, 1970.)
brane,22'2’’ congenital structures, or de­
ficient musculature.
Histologic studies of such a functionally 
obstructive segment revealed a much 
simpler etiology: these segments have an 
abundance of circularly oriented fibres 
(Fig. 11) (instead of the normal mixture 
of fibres running in every direction), which 
act as a sphincter and commonly involve 
the juxtavesical ureter.26 Is this abnormal 
muscular orientation caused by a lack of 
ureteral stretching at this particular level 
during embryonic life with persistence of 
the embryonic circular orientation of 
muscle fibres? It is an attractive hypothesis 
that is hard to prove, but experimentally 
we have been able to induce persistence of 
the circular orientation in the fetal ureter,3 
and the fact remains that this abnormal 
muscular arrangement is the obstructive
Fig. 12.—(A) The course of a helical ureteral 
muscle bundle. (B) Stretching every segment 1/2 
times results in a tube IS  times longer and wider. 
(C) Stretching causes tortuosity because of the 
relative fixation of the ureter at both ends.
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Fig. 13.—(A) Cross-section of an empty ureter. ( B) The same ureteral segment distended under 
20 cm. fLO pressure. Note the available intraluminal capacity under such low pressure (Trichrome 
stain X 5).
mechanism. Once the non-stenosed func­
tionally obstructive segment is resected, 
adequate ureteral drainage is restored.
The ureter in cases of functional obstruc­
tion, unlike those of primary vesicoureteral 
reflux, has normal musculature and re­
sponds to this obstruction by dilatation 
and also by muscular hypertrophy or over­
activity. Results after repair of these cases, 
especially with massive ureteral dilatation, 
are better than for a similar degree of dila­
tation in cases of primary reflux. This dif­
ference is primarily owing to the status 
of ureteral musculature before the obstruc­
tive phenomenon affects the ureters.
D iscussion
Effect of Increased Intraluminal
Volumes
A single helical muscle bundle, like any 
other smooth muscle bundle, will undergo
stretching and lengthening when subjected 
to increased intraluminal volume (Fig. 12). 
A longitudinal segment of the helix will 
enlarge longitudinally, a transverse seg­
ment transversely. This is what happens in 
the ureter as a whole. Where the fibres 
have a circular orientation ( as in the renal 
pelvis), the increase will be more along a 
transverse axis with minimal lengthening. 
Where the fibres have a longitudinal 
orientation, the increase will be along a 
longitudinal axis with tremendous length­
ening and minimal or no widening. As 
seen histologically, the ureter has an equal 
mixture of fibres running in every direc­
tion and will probably increase along every 
axis equally.27 If it doubles its lumen, it 
will probably also double its length. How­
ever, the intravesical ureter has a purely 
longitudinal fibre orientation, which is 
probably why it does not share in ureteral 
dilatation and why a dilated ureter always
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Fig. 14.—(A) Intravenous pyelogram of a patient with right lower ureteral obstruction. (B) Intravenous pyelogram three weeks after operation showing marked regression in ureteral dilatation.
tapers down to a fairly normal-sized intra­
vesical ureter.
The first effect of increased intraluminal 
volume, before it starts to stretch the heli­
cal fibres, is to fill the available ureteral 
lumen, which is appreciably wider than we 
have been accustomed to visualizing by 
means of intravenous pyelograms (Fig. 13). 
Lately, by infusion pyelography, we have 
been able to visualize the size of the intra­
luminal diameter of the ureter before 
pathologic dilatation. Until accumulating 
urine has filled the reserve capacity of the ureteral lumen, there is an increase only in ureteral diameter with no increase in length. After the reserve capacity has been used up, dilatation and tortuosity of the ureter occur as pathologic phenomena of overstretching. The resultant length of the chronically obstructed ureter can be twice or three times normal with a similar degree of dilatation. The ureter is relatively fixed 
at both ends and any increase in its length will lead to a tortuous course.
Reversibility
An acutely obstructed ureter can recover 
once the obstructive mechanism is cor­
rected (Fig. 14).28 However, a severe and prolonged obstruction, especially if it is 
associated with infection, could cause 
serious ureteral damage and markedly 
limit recovery even with the freest drain­
age.Another major factor limiting reversi­
bility is the degree of ureteral muscular development existing before the onset of ureteral dilatation. Poorly muscularized 
ureters, commonly encountered in severe 
vesicoureteral reflux19 and probably in some patients with prune-belly syndrome, have a limited ability to recover. Such ureters may fail to recover and continue to dilate and decompensate even after correc­
tion of reflux, probably because they can­not handle even normal resistance at the site of reimplantation. Nothing short of the direct free drainage of diversion would 
help these patients. Even this may not lead
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to ureteral recovery, but it may stop 
further dilatation. Ureteral muscular de­
velopment and activity should always be 
considered when choosing the best man­
agement for each individual patient with 
dilated ureters, especially massively de­
compensated ureters.
S u m m a r y
The ureter has only one muscular coat 
whose individual muscle bundles have an 
irregular helical arrangement. Increased 
intraluminal volumes stretch these muscle 
bundles equally in every direction, leading 
to dilatation and lengthening.
Several physiologic states lead to ureteral 
dilatation: (1 )  increased urine volume
(diuresis); (2 )  increased normal resistance 
at the ureterovesical junction (bladder 
filling); and (3 ) muscular atony (preg­
nancy and contraceptive pills). Pathologic 
ureteral dilatation is due to: (1) mechani­
cal obstruction (stones, tumours); (2 )  
vesicoureteral reflux owing to the impact 
of repeated overstretching, high pressures, 
increased volumes, and congenital muscu­
lar weakness; (3 )  infra vesical obstruction 
or neurogenic vesical dysfunction because 
of trigonal hypertrophy aggravated by tri­
gonal stretching due to variable residual 
urine; (4 )  trigonal irritation and spasm; 
and (5 ) functional ureteral obstruction due 
to derangement in muscle fibre orientation, 
commonly in the juxtavesical ureter.
The ureter has a remarkable capacity for 
recovery unless its musculature is congeni­
tally deficient or pathologically fibrosed.
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R e s u m e
L’uretere ne possede qu’une seule couche mus- 
culaire, dont les faisceaux individuels sont disposes 
en helice irreguliere. L’augmentation de volume 
du calibre interieur etire ces faisceaux musculaires 
egalement dans toutes les directions et aboutit a 
la dilatation et a l’allongement.
Plusieurs facteurs physiologiques conduisent a 
la dilatation des ureteres: (1 )  augmentation du 
volume urinaire (diurese); (2 )  augmentation de 
la resistance normale de la jonction uretero- 
vesicale (remplissage de la vessie) et (3 )  atonie 
musculaire ( etat de grossesse et contraceptifs).
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La dilatation pathologique de l’uretere est causee 
par: (1 )  une obstruction mccanique ( calculs, 
tumeurs); (2 )  un reflux vesico-ureteral provoque 
par l’impact (retirements excessifs et repetes, par 
des pressions elevees, des volumes urinaires aug­
m en ts  et par une faiblesse musculaire congeni- 
tale; (3 )  une obstruction infravesicale ou un 
trouble fonctionnel de la vessie d’origine neuro­
gene, par exemple par une hypertrophie du tri­
gone aggravee par un etirement dudit trigone
sous l’influence d’un residu urinaire variable; (4 )  
une irritation et un spasme du trigone et (5 )  par 
une obstruction fonctionnelle de l’uretere causee 
par un derangement de l’orientation des fibres 
musculaires, souvent au niveau de la portion 
juxtavesicale de l’uretere.
L ’uretere a une capacite de recuperation re- 
marquable, a moins que sa musculature ne soit 
deficiente congenitalement ou soit le siege dune 
fibrose pathologique.
INTIMAL DAMAGE AFTER FOGARTY CATHETERIZATION OF 
CANINE FEMORAL ARTERIES0
J. F . A. VANCE, M .D.,f D. W. JIRSCH, M .D.,t 
H. T. G. WILLIAMS, M.D., Ch.B., F.R.C.S.fEng. & C], F.A.C.S. and 
C. M. COUVES, M.D., F.R .C.S.(Edin. & C ), F.A.C.S., Edm onton, Alta.
D espite advances in techniques of peri­
pheral embolectomy, reocclusion of em- 
bolectomized vessels remains a perplexing 
problem. In an effort to understand further 
the phenomenon of thrombotic reocclusion 
following embolectomy, we attempted to 
assess the arterial damage produced by 
successive passages of the Fogarty embo­
lectomy catheter.
Method
Fifteen adult mongrel dogs, weighing 
15 to 32 kg., were used in this study. All 
animals were anesthetized with sodium 
pentobarbital and underwent a left total 
pneumonectomy in association with an­
other project. Immediately after this pro­
cedure, both femoral arteries were exposed 
and controlled with angled DeBakey 
clamps proximally and umbilical tapes 
distally. Transverse arteriotomy incisions 
were made in both arteries. After arterio­
tomy, a 5-cm. segment of the left femoral 
artery was excised and placed in 10%
* From the Surgical-Medical Research Institute, 
The University of Alberta, Edmonton, Alta.
This work was supported in part by Medical Re­
search Council of Canada Grant MA-2553. 
tFellow , Medical Research Council of Canada.
Reprint address: Dr. D. W . Jirsch, Surgical-
Medical Research Institute, The University of 
Alberta, Edmonton, Alta.
formalin. These arteries served as controls. 
The excised segment began 2 cm. below 
the arteriotomy and extended distally. On 
the right side, a No. 5 Fogarty catheter 
was passed distally in the femoral artery, 
the balloon inflated to a volume of 1.5 c.c., 
and the catheter withdrawn. There were 
five dogs in each of the three groups: those 
in which the right femoral artery was 
catheterized once; those in which the 
artery was catheterized twice; and those in 
which the artery was catheterized three 
times. After catheterization, a 5-cm. seg­
ment of the right femoral artery was ex­
cised and placed in 10% formalin. The 
catheter was introduced and withdrawn 
smoothly and, in each dog, if resistance 
was encountered, the balloon pressure was 
decreased. No catheter bulbs were rup­
tured intra-arterially.
Longitudinal and transverse sections of 
all arteries were stained with both hema­
toxylin and eosin and Weigert’s stain and 
were examined histologically.
Obsebvations
Control Arteries
These arteries showed a uniformly well- 
preserved intima with only minor areas of 
fragmentation (Fig. 1). These areas were 
focal and superficial, and we noted no sub-
January 1972 FOGARTY CATHETERIZATION 15
y
»
►
y
t
V
V
T'
y
Fig. 1.—Control artery. The intima appears to be intact (Weigert’s stain, original 
magnification X 100).
intimal hemorrhage nor damage to the 
muscle layers of the vessel wall. Most of 
the changes noted appeared to be cutting 
artefacts and were predominantly in folded 
or cracked sections.
Arteries Subjected to Fogarty
Catheterization
These vessels all contained areas of in­
timal stripping of variable length. Patho­
logical changes were more severe than 
could be expected from cutting artefacts 
and were also found in cleanly cut and 
well-preserved specimens. Although the in­
timal loss was more marked in arteries 
subjected to two or three passages of the 
catheter, the limited number of sections 
did not justify further correlation. In a few 
sections we noted a mild degree of sub- 
intimal disruption but no significant sub- 
intimal hemorrhage or damage to muscle 
layers (Figs. 2-4).
D iscussion
The arteries studied were those of 
healthy young dogs and they were not 
damaged either by atherosclerosis or by 
impaction of an embolus. In addition, they 
were removed immediately after smooth
passage(s) of the Fogarty catheter, al­
though we realized that arteries previously 
damaged by disease or left in situ for 
longer periods after catheterization might 
show more marked pathological changes. 
Other factors can augment intimal damage 
during catheterization but we avoided 
these during this study. Overinflation and 
balloon rupture can obviously break inti­
mal continuity but hypoinflation with pre­
sentation of an irregular balloon surface to 
the vessel wall may have a similar effect. 
Catheter withdrawal should be smooth and 
continuous since initial intimal damage will 
probably extend with any irregular force. 
Repetitive instrumentation may be simi­
larly detrimental producing further intimal 
stripping and more extensive subintimal 
hemorrhage and damage to the muscle 
layers.
Intimal denudation alone, as produced 
by our routine introduction and withdrawal 
of a properly inflated catheter, could initi­
ate thrombosis in a normal or diseased 
vessel. Local trauma to the vessel may 
activate tissue thromboplastin at the flow­
ing blood/arterial wall interface and, in 
addition, may neutralize the normal nega­
tive charge of the internal vessel wall. Sub­
sequent aggregates of platelets, fibrin and
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Fig. 2.—Artery after one passage of a No. 5 Fogarty catheter. The intima is frag­
mented in several places (Weigert’s stain, original magnification X 100).
erythrocytes could alter the hemodynamics 
of laminar flow and thereby induce further 
thrombus formation leading eventually to 
occlusion of the vessel. Postoperative anti­
coagulation with heparin might prevent
certain of these effects but it is commonly 
some hours before stable anticoagulation is 
established clinically and, in any event, 
extensive vascular damage may persist.
Our findings are somewhat at variance
Fig. 3.—Artery after two passages of a No. 5 Fogarty catheter. A large area of intima 
has been stripped off (Weigert’s stain, original magnification X 100).
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Fig. 4.—Artery after three passages of a No. 5 Fogarty catheter. Little intirna remains 
in this illustration (Weigert’s stain, original magnification X 100).
with those of Fogarty and Cranley1 who 
stated that the catheter was so designed 
that, within the bounds of surgical caution, 
arterial perforation, plaque disruption, in- 
timal dissection and arterial rupture are 
avoided. The bursting point of the rubber 
jacket was intentionally put far below the 
point that would cause intimal damage. 
However, in a later description of 128 em- 
bolectomies, Krause et al.2 described two 
instances of gross intimal stripping, two of 
plaque dissection and one of arterial per­
foration.
We suggest that intimal damage may 
be more common than previous reports 
imply.11 The catheterized arteries all ap­
peared grossly normal and yet all had some 
degree of microscopic intimal loss.
C o n clusio n s
We conclude that Fogarty catheteriza­
tion does cause immediate arterial wall 
damage. The damage is predominantly 
microscopic intimal loss, although sub- 
intimal disruption was occasionally seen as 
well. We suspect that this damage may be 
progressive with successive passages of the 
catheter, but the number of arteries studied 
does not warrant a definite conclusion in 
this regard.
We postulate that the intimal loss ob­
served in these arteries may play a role in 
the vessel thrombosis and reocclusion that 
occasionally follow peripheral embolec- 
tomy.
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R e s u m e
Les auteurs ont etudie histologiquement, chez 
15 chiens batards adultes, des segments des deux 
arteres femorales. Ils ont excise, apres arterio- 
tomie, des segments des arteres femorales gauches, 
pour servir de temoins. Quant aux segments des 
arteres femorales droites, ils n’ont ete excises 
qu’apres un certain nombre de passages (un, deux 
et trois) d’un catheter de Fogarty No 5. Au 
point de vue histologique, les arteres-temoins 
etaient nonnales. Par contre, certaines sections 
des arteres catheterisees revelaient soit la frag­
mentation, soit la perte de l’intima. La fragmen­
tation subintimale n’a ete notee qu’occasionnelle- 
ment. L ’ampleur de la lesion de 1’intima etait 
directement proportionnelle au nombre de pas­
sages du catheter.
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ELEM ENTAL DIET IN THE MANAGEMENT OF THE INTESTINAL 
LESIONS PRODUCED BY RADIATION IN THE MOUSE0
J. S. HUGON, M.D.t and G. BOUNOUS, Sherbrooke, Que.
T h e  lesions produced by x or y rays have 
been intensively studied.1'5 The first tissues 
to be damaged are the intestinal mucosa 
and the hematopoietic system. Depending 
on the dose, the dividing undifferentiated 
cells of the intestinal crypt are arrested in 
mitosis or killed and, eventually, these 
cells are extruded into the lumen of the 
intestine. These lesions produce a more or 
less extensive desquamation of the intesti­
nal epithelium and, subsequently, mal­
absorption.
To prevent this radiation enteropathy, 
several radioprotective drugs have been 
used in animals. Nearly all of them are 
toxic and can be lethal if administered for 
several days.8 However, when injected a 
few minutes before the irradiation, they 
provide a high level of protection.7
Another way to manage the intestinal 
lesion is to enhance the process of repair in 
order to promote a faster renewal of ab­
sorptive cells. It is for this purpose that we 
have studied the effect of an elemental 
diet. Previous experiments have shown the 
value of this diet in protecting the intesti­
nal epithelium in ischemic enteropathy8 
and in 5-fluorouracil (5-FU ) injury.9’ 10
M a t e r ia l  a n d  M ethods
Swiss ICR male mice, 3 months old, 
were used in all experiments. The effects 
of y radiation on 30-day survival and the 
morphology of the intestine were recorded 
using different dietary regimens.
Diets
Three types of diet were used:10
The first (Diet A) was Purina chow.
"Supported by the National Defence Research 
Board and the Medical Research Council of 
Canada.
fAssociate Professor of Pathology, Centre Hospi- 
talier Universitaire, University of Sherbrooke, 
Sherbrooke, Que.
^Associate Professor of Surgery, Centre Hospi­
taller Universitaire, University of Sherbrooke; 
Research Associate, Medical Research Council of 
Canada.
The second (Diet B) was the test or 
elemental diet and consisted of highly 
hydrolyzed food. The composition of this 
diet (Mead Johnson product 3200-A.S.) 
was described in a previous publication.10
The third (Diet C) differed from Diet B 
only in that the enzymatic casein hydro­
lysate was replaced by an equal amount 
of whole casein.
All these diets were administered ad  
libitum  in powder form from stainless steel 
cups designed to reduce spillage. All ani­
mals drank water ad libitum  and were 
housed on stainless grids to prevent 
coprophagy. The diets were administered 
for seven days before the irradiation and 
continued until the death of the animals 
or the end of the test period.
Irradiation
Mice were confined in a specially con­
structed plastic circular holder divided into 
15 compartments and were exposed from 
a dorsoventral direction to a y-ray beam 
from a cobalt-60 source at a dose rate of 
100 R./min. Doses of 700, 900, 1000 and 
1350 rads were used. All animals were 
irradiated in the afternoon. The test diet 
group was paired with its control group.
Mortality
The mortality was studied over a 30-day 
period.
In the first experiment, 20 mice received 
Diet A (Purina) and 20 received Diet B 
(elemental). They were irradiated with 
900 rads. In the second experiment, 30 
mice received Diet C (whole casein) and 
30 Diet B (elemental). They were irradi­
ated with 900 rads. In the third experi­
ment, 30 mice received Diet A (Purina) 
and 30 Diet B (elemental). They were 
irradiated with 1000 rads.
In each experiment, the test group was 
irradiated at the same time as its own 
paired control group. However, the three 
experiments were made at different times; 
for example, the first experiment was
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carried out in the fall, while the second 
was done in the winter.
The animals were weighed seven days 
before irradiation, on the day of irradia­
tion, and at 10 and 30 days thereafter.
glutaraldehyde and embedded in Epon for 
the electron microscopic study.
For statistical analysis of mortality rates, 
we used a two tailed t test based on the 
original number of mice, and the number
TABLE I.—W e ig h t  (g .) of M ic e  B e f o r e  an d  A f t e r  900 R ads y R a y s .
N u m b e r  o f  M ice  in  B r a c k e t s
I II  III  IV
Diet C (30) (whole casein) 41.59 ±  3.71 39.05 ±  2.99 34.15 ±  4.38 32.93 ±  2.77* (10)
Diet B (30 (elemental) 40.14 ±  3.76 40.85 ±  4.90 36.60 ±  4.06 38.68 ±  3 .99f (19)
I = weight before the diet; II =  weight after one week of diet (day of irradiation); III =  weight 10 days
after 900 rads of y  rays; IV = weight of survivors 30 days after irradiation.
*vs; fP <  0.001.
Histologic Study
Only the first part of the jejunum was 
studied. In a first experiment, 30 mice re­
ceived Diet C (whole casein) and 30 Diet 
B (elemental). They were irradiated with 
700 rads and sacrificed at one, two, three, 
four, five and six days. In a second experi­
ment, 10 mice received Diet A (Purina) 
and 10 Diet B (elemental). They were 
irradiated with 900 rads and sacrificed at 
one and four days. In a third experiment, 
10 mice received Diet A (Purina) and 10 
Diet B (elemental). They were irradiated 
with 1350 rads and sacrificed at three and 
six days.
The jejunum was fixed by immersion in 
alcoholic Bouin and processed to paraf­
fin embedding. Hematoxylin-eosin and 
periodic acid-Schiff staining were used.
Electron Microscopic Study
In each of the preceding experiments, 
blocks of jejunal epithelium were im­
mersed in 1% phosphate-buffered osmium 
tetroxide or in 3% cacodylate-buffered
of surviving and dead animals at 30 days.
Mitotic Index
In a first series of experiments, nine mice 
received Diet C (whole casein) and nine 
Diet B (elemental). They were irradiated 
with 700 rads and sacrificed at two, three 
and four days after irradiation.
In a second series of experiments, nine 
mice received Diet C and nine Diet B. 
They were irradiated with 1000 rads and 
sacrificed at two, four and six days after 
irradiation.
The mitotic index was evaluated on 2000 
nuclei in the jejunal crypts of each animal. 
The number of nuclei per crypt was also 
measured.
Results
Weight
Table I shows the weight of the mice at 
different time intervals in relation to 
irradiation. The first group ate Diet C 
(whole casein) and the second Diet B 
(elemental); the difference in weight be-
T A B L E  II.—E ff e c t  o f  D ie t  on  R a d ia t io n  D eath  in  M ice
Nc. of 
mice
Cumulative mortality 
(days) %
mortality at 
SO days7 U 21 SO
Diet A (Purina) 900 rads 20 4 12 16 17 85 *
Diet B 900 rads 20 0 7 11 11 55 f
(elemental 3200-A.S.)
Diet C (whole casein) 900 rads 30 3 18 20 20 05.5J
Diet B 900 rads 30 6 11 11 11 33.38
(elemental 3200-A.S.)
Diet A (Purina) 1000 rads 30 4 29 30 30 100
Diet B (elemental) 1000 rads 30 5 29 30 30 100
'vs; |P < 0.02; Jvs; §P <  0.005.
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Fig. 3.—Light microscopy, 1350 rads, six days, 
Diet A. The mucosal epithelium of the villi is still 
irregular with some foamy cells. Two karyolytic 
bodies are seen embedded in absorbing cells 
(original magnification X 214).
Fig. 4.—Light microscopy, 1350 rads, six days, 
Diet B. The layer of mucosal cells is continuous 
on the villi. The cells are tall and appear nonnal 
(original magnification X 214).
Fig. 1.—Light microscopy, 700 rads, 24 hours, 
Diet C. Clear vacuoles are observed at the tips 
of the villi (arrow), above the nuclei (X 214).
tween the two groups was not significant 
before irradiation. However, at the end of 
the experiment, the weight of the survivors 
taking the elemental diet (Diet B ) was 
significantly higher (P <  0.001) than that 
of the survivors eating Diet C (whole 
casein). The two diets maintained body 
weight before irradiation.
Fig. 2.—Light microscopy, 700 rads, 24 hours, 
Diet B. No such clear areas are noted (X 214).
Mortality
Table II shows the mortality in the three 
different experiments. The following con­
clusions may be drawn.
In the first experiment (900 rads), the 
mice taking the elemental diet (Diet B) 
had a lower 30-day mortality rate than 
controls taking Purina (Diet A ). In the 
same experiment all the mice taking the
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Fig. 5.—Light microscopy, 1350 rads, three 
days, Diet A. Villi are extremely atrophic with 
cuboidal cells. Crypts are irregular with several 
nests of undifferentiated cells dispersed in the 
lamina propria (original magnification X 214).
elemental diet were alive at seven days 
while four of the control group died.
In the second experiment (900 rads), 
the mice eating the elemental diet again 
had a lower 30-day mortality rate than the 
group eating whole casein (Diet C ).
In the third experiment (1000 rads), the 
two groups of mice ran the same course 
with no survival after a 30-day period.
Light Microscopy (Figs. 1 to 6)
Jejunal morphology was studied on sec­
tions stained with hematoxylin and eosin. 
Doses of y rays were 700 rads, 900 rads 
and 1350 rads.
700 racls.—'Twenty-four hours after ir­
radiation, the lesions of the undilferentiated 
cells of the crypts were similar in the two 
groups of mice regardless of diet. How­
ever, at the tip of the villi, large empty
Fig. 6.—Light microscopy, 1350 rads, three 
days, Diet B. Villi are atrophic. The crypt is taller 
than in Fig. 5. Moreover, at the mouth of the 
crypt, near normal absorbing cells begin to mi­
grate on the villi (original magnification X 214).
vacuoles were observed above the nuclei 
in those on whole casein but they were 
absent in those on the elemental diet.
Forty-eight hours after irradiation, 
mitosis was equal in the undifferentiated 
cells of both groups.
After three days we could identify no 
differences between the two groups be­
cause the mucosal epithelium was normal.
900 rad s— Twenty-four hours after ir­
radiation, the same lesions were observed 
in both groups, i.e. numerous karyolytic 
bodies in the crypt cells with desquama­
tion in the lumen of the crypts.
Four days after irradiation, the columnar 
cells of the jejunal villi were taller in the 
mice taking the elemental diet than in the 
group eating Purina. Similarly the lesions 
of the crypts had totally disappeared in the 
group eating the elemental diet.
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Fig. 7.—Electron microscopy, 900 rads, four days, Diet A, absorbing cells of the villus. The 
microvilli are irregular, some are fused. Smooth endoplasmic reticulum is dilated. Numerous large 
and small lipid vacuoles are seen (x 19,900).
Fig. 8.—Electron microscopy, 900 rads, four days, Diet B, absorbing cells of the villus. The 
microvilli are regular. Mitochondria present numerous dense granules. No lipid droplets are observed 
besides small aggregates in the Golgi cisternae. Large cytosomes are present in the supranuclear 
region (x 7700).
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Fig. 9.—Electron microscopy, 900 rads, four days, Diet A, Golgi zone. Large vacuoles with 
lipid droplets are seen. Lipid granules are present between the cells (arrow) (x 30,780).
1350 rad s— In the two groups, the mor­
tality was high and on the sixth day the 
survivors appeared very ill.
Three days after irradiation, the villi 
were atrophied in both groups and showed 
small clear cells. However, more blunt villi 
were still covered with a layer of flat cells 
in the animals taking the elemental diet 
than in the group eating Purina.
Six days after irradiation, in the sur­
vivors, the mucosal epithelium was nearly 
normal in the elemental diet group but 
still flat and irregular in the Diet A group.
Electron Microscopy (Figs. 7 to 10)
The lesions seen in the crypt cells of all 
mice were similar to those already 
described after x- or y-ray irradiation re­
gardless of the diet taken.3’ 4 However, in 
the villi of animals not taking the elemen­
tal diet, the absorbing cells situated at the 
apex of the villi showed numerous large 
lipid vacuoles packed in the cytoplasm. 
This finding, which was evident 24 hours 
after 700 rads and four days after 900 rads, 
is of considerable interest because these
mice had always fasted for 18 hours be­
fore radiation. In the elemental diet ani­
mals, very few small lipid granules were 
occasionally seen in the same area.
Four days after 1350 rads of y rays, 
there was severe atrophy of the columnar 
cells of the mice eating the elemental diet. 
Cuboidal cells with small microvilli and 
numerous cytoplasmic vesicles covered the 
villi. Mitochondria were vacuolated. In the 
control animals, the lesions were more 
severe and large sheets of epithelium had 
disappeared. The remaining absorptive 
cells were flat with small microvilli, large 
dilatation of endoplasmic reticulum and 
accumulation of lipids.
Mitotic Index
Table III shows the number of mitoses 
and number of nuclei per crypt in two 
different series of experiments. In mice re­
ceiving Diet B, the number of mitoses per 
crypt is significantly higher (P  <  0.0005) 
on the third day after 700 rads and on the 
fourth and sixth day after 1000 rads than 
in controls receiving Diet C.
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Fig. 10.—Electron microscopy, 1350 rads, four days, Diet A, absorbing cells of the villi. Flat elongated cells with irregular nuclei and condensed nucleoli are seen. The microvilli are atrophic. A goblet cell with a few mucous granules can be seen. Lipid areas are dispersed in the cytoplasm (x
D i s c u s s i o n
This study indicates that ingestion of an elemental diet benefits mice receiving y  
radiation. This benefit is evident in the 
histology of the intestinal mucosa regard­less of the radiation dose given and it is 
crucial enough to improve survival of the mice receiving 900 rads.
Examination of the histology of the 
jejunal mucosa makes it possible to specu­
late on the type of protection given by an elemental diet as well as the possible mechanism involved.
The early radiation lesions seen on the
first day are most striking in the crypts 
where mitotic figures were arrested or de­
stroyed. This change was unaffected by the 
diet at all levels of radiation. This finding suggests that an elemental diet does not 
protect the crypts against radiation injury. 
However, the crypts recovered more 
rapidly from this injury when the elemen­tal diet was taken.
We have confirmed that the more mature cells seen on the villi also suffer, 
as evidenced by the accumulation of lipids 
and the presence of vacuoles appearing at 
24 hours. This type of lesion, which, as ex-
TABLE II I .—E f f e c t  o f  D i e t  o n  M it o s is  a n d  o n  N u m b e r  o f  N u c l e i  p e r  C r y p t  
in  t h e  J e ju n u m  o f  M ic e  A f t e r  7 - ra y  I r r a d ia t io n . T h r e e  M ic e  in  E a ch  C a s e . 20 0 0  N u c l e i  p e r  M o u s e
2  d a y s 3  d a y s 4 d a y s 6  d a y s
D ie t  C *  D ie t  B t D ie t  C  D ie t  B D ie t  C  D ie t  B D ie t C  D ie t  B
Mitosis per crypt 1000 rads 
700 rads
0.39 + 0.11 0.62 + 0.09 P <  0.050.99 + 0.35 0.77 ± 0.28 P <  0.15 1.25 + 0.09 2.13 + 0.34 P <  0.0005
2.25 + 0.22 4.16 + 0.45 P <  0.00051.88 + 0.26 2.20 + 0.55 P <  0.1
1.91 + 0.35 3.00 + 0.35 P <  0.0005
Nuclei per crypt 1000 rads 
700 rads
26.33 + 0.9 28.32 + 1.5 P <  0.126.90 ± 2.29 26.83 ± 3.56 46.36 ± 4.45 52.83 ± 2.40 P <  0.0025
71.6 + 5.8 79.5 ±  3.2 P <  0.01264.31 ± 4.16 49.78 ± 13.99 P <  0.01
69.0 ± 8.46 79.83 ± 3.76 P <  0.02
♦Whole casein; f  Elemental.
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pected, is more severe as the radiation dose 
increases, was definitely milder in the ele­
mental-diet animals. Also, the beneficial 
effect of the diet became increasingly 
obvious with the passage of time after 
injury.
We interpret these results to mean that 
an elemental diet probably does not affect 
the initial radiation damage but facilitates 
the process of repair.
Sufficient data is available to suggest a 
likely explanation for the mechanism of 
action of the elemental diet. The utiliza­
tion of carbohydrates and proteins from 
the chyme by the intestinal mucosa nor­
mally requires a terminal process of hydro­
lysis, which occurs in the absorbing epi­
thelium. This step is essential for proteins 
which are found in the intestinal lumen 
mostly in the form of peptones. We have 
already shown that the intestinal lesion 
produced by 5-FU is accompanied by an 
apparently selective fall in peptidase ac­
tivity in the absorbing cells.9 We have also 
noted a great similarity between radiation 
and 5-FU enteropathies. It is conceivable 
that irradiation has a similar effect on these 
intestinal enzymes, thereby hampering pro­
tein utilization and cellular repair. This 
would also explain the inability of the in­
jured cells in our control animals to mobi­
lize the absorbed fat and to transport it 
into the lacteals. Indeed it is known that 
intracellular protein synthesis is necessary 
for chylomicron formation. It is obvious 
that mice eating proteins in the form of 
amino acids can dispense with the process 
of cellular hydrolysis and can both absorb 
and utilize these nutrients. Furthermore, 
rats on an elemental diet show an apparent 
drop in mucosal cellular peptidase activity.® 
This decreased activity, however, may be 
attributed to a selective decay of the en­
zyme when the tissue is preserved frozen.
We are investigating this possibility. 
Our hypothesis concerning the mechan­
ism of action of the elemental diet rests 
to a large extent on the observation 
that mice taking a diet which differs only 
by the presence of the same proteins in a 
non-hydrolyzed state (whole casein, Diet 
C) do not show any significant improve­
ment over control mice eating Purina chow 
(Diet A).
The ingestion of amino acids may not 
only facilitate the process of repair in the 
intestinal mucosa but may also provide for 
the synthesis of proteins that are essential 
to the recovery of other tissues damaged 
by radiation, such as the bone marrow and 
liver. This could explain the improved 
survival rates obtained with the elemental 
diet at the 900-rad dose level.
The effect of radiation on intestinal en­
zymes is known to some extent.11,12 Gal- 
jaard et al.13 and Spiro and Pearse14 have 
shown that low doses of x rays (400 R) 
do not modify the enzymatic content of the 
villus mucosa in the first days following 
irradiation. But with higher doses, which 
cause considerable cell damage, significant 
decrease of enzymatic activity including 
peptidase has been reported.15
Table II shows that mice eating the ele­
mental diet and receiving the same radia­
tion dose in the first and second experi­
ments had different 30-day mortality rates. 
This can probably be explained by the fact 
that the experiments were carried out at 
different seasons of the year. In addition, 
the mortality of the control group in each 
experiment was similarly affected so that 
the ratio of mortality between the paired 
groups in each experiment was identical.
The effect of nutrition on the response to 
radiation has been studied by several 
authors.16 Protein depletion was shown to 
increase the susceptibility to total body ir­
radiation.17 Walburg, Mynatt and Robie,18 
studying the mortality of irradiated germ- 
free mice, observed that the animals sup­
plemented with a synthetic diet formed by 
pure amino acid, vitamins and salts pre­
sented a slope of the mortality curve, an 
increase of the LD-)0/ (30) and a decrease 
of the weight loss after irradiation. On the 
other hand, Smith and Tyree19 demonstrat­
ed in irradiated rats that forced feeding by 
stomach tube or by subcutaneous injection 
is harmful after small dosages of irradia­
tion.
Regarding the optimal protein require­
ments in the face of severe injury, Mark- 
ley, Smallman and Thornton,20 in a study 
of burn mortality in mice, found that the 
protein content of diet should be between 
8%  and 12%. This corresponds to the pro­
tein content of our Diets B and C.
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While the intestinal radiation lesion is 
similar in man and rodents, more work will 
be required to determine to what extent 
elemental diets will be applicable clinically 
in humans subjected to abdominal irradia­
tion.
Summary
An elemental diet (Mead Johnson 3200- 
A.S.) containing amino acids instead of 
proteins has been shown to improve sig­
nificantly the 30-day survival in mice fol­
lowing 900 rads of y rays.
The elemental diet also produced sig­
nificant benefit in the intestinal mucosa. 
The initial radiation damage in the intesti­
nal crypts was unaffected by the dietary 
regimen, but the elemental diet led to a 
faster recovery from such lesions and the 
mitotic index was higher in these animals. 
In the absorbing cells of the villi, the ini­
tial lesion was lessened by the elemental 
diet and the repair process was greatly 
facilitated.
Presumably, irradiation impairs the 
ability of the intestinal mucosa to perform 
terminal digestion of protein; hence inges­
tion of amino acids is beneficial because 
such terminal digestion is no longer neces­
sary.
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Resume
Une diete elementaire (Mead Johnson 3200- 
A.S.) dont toutes les proteines sont hydrolysees 
sous forme d’acides amines, ameliore significative- 
ment la survie de souris irradiees par 900 rads de 
rayons 7 . La reparation morphologique de la 
muqueuse intestinale semble egalement facilitee. 
Si les lesions immediates au niveau des cryptes ne 
sont pas modifiees par le regime, il semble par 
contre, que les cellules absorbantes des villosites 
retrouvent plus rapidement leur integrite. De plus 
la reprise mitotique est acceleree. Le fait que 
1’hydrolyse des proteines alimentaires est pro- 
bablement perturbee par l’irradiation, pourrait ex- 
pliquer le role benefique d’une diete foumissant 
directement des acides amines.
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BLOODSTREAM IN FECTIO N  ASSOCIATED W ITH  
PROLONGED INTRAVENOUS THERAPY0
N. D. COLAPINTO, M.D., P. BEDARD, M.D. and B. S. GOLDMAN, M.D., F.R.C.S.[C],
Toronto, Ont.
Intravenous infusions are an essential part 
of daily patient care. They are often em­
ployed for many days because o f illnesses 
requiring prolonged fluid, electrolyte, anti­
biotic or metabolic therapy. Multiple vene­
punctures are disturbing to the patient and 
costly in time to hospital personnel. Thus, 
plastic intravenous cannulas have been de­
veloped which have less tendency to allow 
fluid to escape into the tissues or becom e 
obstructed by thrombus. These cannulas 
may then remain in situ and function for 
a considerable time. Recently, numerous 
sources o f hospital-acquired infections have 
been recognized and documented. The 
purpose of this paper is to stress that the 
common intravenous infusion should not be 
considered casually; intravenous therapy, 
and in particular the intravenous cannula, 
may be the source of a significant number 
of bloodstream infections.
Our interest was stimulated by two epi­
sodes of septicemia occurring within a 
single week.
Case Reports
Case 1.—J.T. developed a severe unexplain­
ed deep thrombophlebitis in the right lower 
limb following vigorous exercise. She was 
treated with bed rest and intravenous heparin, 
given as two-hourly injections into a con­
tinuous drip. Being an anxious young girl, she 
nursed the intravenous carefully in order to 
avoid a second venepuncture. After eight days 
with the same plastic cannula in place, her 
oral temperature inexplicably spiked to 105° F. 
Blood cultures were taken and antibiotic 
therapy was begun, after which her tempera­
ture returned to normal. The next day her 
temperature again rose dramatically to 107° F. 
and she had shaking chills, cyanosis and an 
apical rate of 180 beats per minute. Aside 
from general supportive measures, significant
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management included removal of the intra­
venous cannula. Following this, her condition 
improved and her temperature rapidly re­
turned to normal. She had no further recur­
rence and remained well (vide infra).
Case 2.—J.G. developed deep thrombo­
phlebitis six days after prosthetic replacement 
of a diseased aortic valve. On the fourth day 
of intravenous heparin therapy, his tempera­
ture rose suddenly to 105° F. accompanied 
by a single chill. Having been alerted to the 
possibility of the intravenous tubing or infu­
sion acting as a source of infection, the can­
nula was promptly removed. His symptoms 
rapidly subsided with no other treatment and 
with no recurrence.
In both these patients no source o f en­
dogenous infection was ever demonstrated. 
In both instances, cultures taken from the 
intravenous puncture site and the tip o f 
the plastic cannula grew the identical 
organism cultures from the bloodstream 
(E . coli in the first, and P. aeruginosa in 
the second case).
Having become aware o f this problem, 
we were able to demonstrate that the intra­
venous cannula was the source o f b lood ­
stream infection in three other patients 
during the next two months.
Possible Sources of Bloodstream
C ontamination D uring Prolonged
Intravenous T herapy
(1 )  The first obvious source is the 
bottle; the solution may have been con­
taminated during manufacture. A  more 
common source is the unfiltered vent in­
serted into the bottle, which may allow 
airborne contamination to be sucked in 
with each drop of fluid.
(2 )  Other sources are related to poor 
nursing technique and casual handling. 
Intravenous medications are often inserted 
directly into the bottle or into the side-arm 
of the plastic tubing. T oo  often, no anti­
septic wipe is used or the medications are
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injected before the antiseptic can take 
effect.
(3) The volume-control and blood-filter 
portions of the intravenous tubing become 
an ideal culture medium soon after de­
livery of blood transfusions. Frequently 
this filter system containing clotted blood 
is left in the intravenous line for a con­
siderable period.
(4) The “piggy-back” intravenous is a 
simple way to deliver two solutions through 
a single route. It consists of the needle of 
one intravenous line inserted into the side- 
arm of another. Unfortunately, this line is 
often loosely attached with ordinary ad­
hesive tape, permitting sufficient movement 
of the needle to allow contamination. Simi­
larly, the open-ended three-way stopcock, 
inserted to allow flushing of venous and 
arterial pressure lines or to inject medica­
tions, often lies exposed to contaminants.
(5) The technique of inserting an intra­
venous cannula probably contributes more 
to the development of sepsis than those 
factors already mentioned. A cursory wipe 
of the skin with a mild antiseptic solution, 
followed by the unsterile fingers feeling the 
vein must certainly deliver skin bacteria to 
the end of the cannula. There is, further­
more, a variable degree of motion of the 
plastic cannula at the puncture site, again 
contaminating the intravenous portion.
D iscu ssio n
Infections acquired in hospital from the 
use of various types of therapeutic equip­
ment are serious and well-recognized prob­
lems. Ventilatory apparatus, including 
anesthetic machines, and indwelling drain­
age systems have been particularly impli­
cated. Intravenous therapy has also been 
described as a source of bloodstream con­
tamination, but it is used so commonly, 
that few have heeded the warnings in the 
literature.
One of the earliest descriptions of hospi­
tal-acquired septicemia from indwelling 
intravenous catheters was reported by 
Neuhof and Seley1 in 1947. Hassall and 
Rountree2 reported their experience with 
staphylococcal septicemia from 1950 to 
1957. In 50% of the 40 patients infected in 
hospital, infection was believed to have 
arisen from the intravenous cannula.
Andriole et al.3 reviewed 21 cases of Can­
dida endocarditis and noted that five of 
these cases were attributed to the use of 
prolonged intravenous therapy for bacterial 
endocarditis. Smits and Freedman,4 in 
1967, reported 98 cases of septicemia and, 
of these, nine were traced directly to the 
intravenous cannulas, all of which had 
been in place for a period of 2% to seven 
days. This study concluded that catheter 
sepsis represented the single most impor­
tant cause of staphylococcal septicemia 
with a significant mortality rate. In 1969 
Darrell and Garrod5 reported three cases 
of septicemia developing from prolonged 
intravenous therapy. Two were due to 
Candida albicans and the third to Staphy­
lococcus aureus; two of the infections were 
fatal. Michaels and Ruebner6 in 1953 
demonstrated organisms flourishing in the 
intravenous bottle in two patients with 
gram-negative septicemia.
Although these and other scattered re­
ports of well-documented individual cases 
have appeared in the literature over the 
years, true awareness of the problem seems 
only recently to have become apparent. 
Collins et al.7 reported a prospective study 
of 213 intravenous cannulas left in place 
for longer than 24 hours. “Local” infection, 
defined as a positive culture of the cannula 
tip, was found in 35%. There was an 
almost linear trend with the duration of 
cannulation. Four cases of cannula septi­
cemia occurred, two of which proved fatal. 
Phlebitis occurred in 39% of the patients; 
the frequency increased as the duration of 
the cannula in situ increased. Surprisingly, 
the presence of phlebitis did not have any 
correlation with the development of sub­
sequent septicemia.
Bentley and Lepper8 described a retro­
spective study of 2556 intravenous units 
which had been in place longer than 24 
hours. The venous catheter was considered 
the source of infection only if no other 
potential source was present. In this study, 
44 cases of septicemia occurred, and the 
intravenous cannula was the commonest 
source of infection (19 cases). The intra­
venous units had been in place an average 
of 5.2 days. Significantly, all septicemias 
occurred with cannulas that had been in 
place 60 hours or more.
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C o n clusio n s
Intravenous therapy, and in particular 
the plastic intravenous cannula, may be a 
source of bloodstream infection.
If the intravenous unit has been in place 
less than 48 hours, septicemia probably 
does not occur. All cannula-related septi­
cemias thus far reported have occurred 
after the intravenous had been in place a 
minimum of 48 hours.
It is estimated that 20% of all hospital- 
acquired septicemias are related to the 
intravenous unit itself. No infections have 
been reported with the use of stainless- 
steel needles. The exact mechanism of in­
dwelling intravenous catheter sepsis is 
unknown. It is probably related to the 
technique of venepuncture, the amount of 
injury to endothelium at the time of inser­
tion, and continued movement of the 
catheter.
Staphylococcus is the causative organism 
with much greater frequency than is gen­
erally seen in septicemias—about 70% 
compared with the usual 15% to 20%.
Systemic antibiotics will not control such 
infections, as long as the intravenous can­
nula remains in situ.
Hospital procedures should insist on an 
aseptic technique for venepuncture, with 
local shave, adequate antiseptic prepara­
tion and perhaps antibiotic creams. Plastic 
cannulas should be used only when neces­
sary, changing the cannula and/or the 
intravenous tubing and volume control or 
filter unit every 48 hours.
In all patients with unexplained septi­
cemia, the intravenous cannula should be 
suspected and promptly removed.
S u m m a r y
We have presented two patients with 
hospital-acquired septicemia arising from
infection at the site of intravenous can- 
nulation. Possible sources of contamination 
are noted for purposes of establishing 
prophylaxis. The most important considera­
tion appears to be aseptic insertion and 
maintenance of the cannulas and frequent 
replacement of the intravenous tubing. The 
intravenous unit should be suspected as the 
source of infection in all cases of un­
explained hospital-acquired septicemia.
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R e s u m e
j Les auteurs presentent deux malades souffrant 
d’une septicemie contractee a l’hopital, l’infection 
ayant pris naissance au siege de la ponction intra- 
veineuse. Ils passent en revue les sources possibles 
de contamination, en vue d’etablir des mesures 
prophylactiques. Le point le plus important est 
de respecter les conditions d’asepsie au moment 
de la ponction, d’entretenir les aiguilles et de 
remplacer souvent les tubes servant a la perfu­
sion intraveineuse. L ’appareillage a intraveineuse 
devrait etre soupgonne d’etre la source de Tinfec- 
tion dans tous les cas de septicemie iatrogene.
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LE CANCER DE L ’CESOPHAGE: RESULTATS THERAPEUTIQUES
L. CONRAD PELLETIER, M.D., F.R.C.S.[C],8 JACQUES BRUNEAU, M.D., F.R.C.S.[C],t 
JEAN-PAUL CHOLETTE, M.D., F.R.C.S.[C]f et JEAN-P. FAUTEUX, M.D., F.R.C.S.[C],t
Montreal, Que.
Malgre le developpement de nouvelles 
techniques chirurgicales et de radiothe- 
rapie, le cancer de l’oesophage demeure 
Tune des lesions tumorales les plus diffi- 
ciles a traiter efficacement et son pronostic 
est encore generalement mauvais. Apres 
resection de la tumeur, le taux de survie de 
cinq ans varie de 6% a 16%.1-4 En 1963, 
Logan" a rapporte une serie personnelle de 
544 cas et revu F experience anterieure de 
Ellis, Nakayama et Sweet. L’ensemble de 
ces quatre series comprenait 1981 cas. Le 
taux de resection allait de 27% a 78% et 
la survie de cinq ans, obtenu par la chirur- 
gie, de 10% a 15%.
En 1962, les resultats du traitment du 
cancer de l’oesophage a FHotel-Dieu de 
Montreal furent releves.8 De 1949 a 1962, 
113 cas avaient ete diagnostiques. Qua- 
rante-six malades avaient recu de la radio­
therapie seulement et 47 avaient subi un 
traitement chirurgical, palliatif pour 27, 
curatif dans 20 cas. La seule technique 
chirurgicale alors employee etait l’oeso- 
phago-gastrectomie. Comparativement aux 
malades non traites, la chirurgie palliative 
n’avait montre aucune amelioration de la 
survie et la radiotherapie employee seule 
s’etait revelee a peine plus efficace. Les 
seules survies de plus d’un an avaient ete 
obtenues avec la chirurgie curative. Vingt- 
cinq pour cent des malades dont la lesion 
avait pu etre enlevee en entier avaient 
survecu plus d’un an et la duree moyenne 
de la survie etait triplee comparativement 
aux autres malades (de cinq a 15 mois). 
Cependant, la survie maximum fut de 
quatre ans, dans un cas. Meme si la chirur­
gie curatrice semblait donner les resultats 
les plus favorables, l’absence de survivant 
a long terme indiquait la necessite de re­
viser le traitement de ces malades.
‘’Mayo Clinic, Rochester, Minn. 55901, U.S.A.
JDepartement de chirurgie, Hotel-Dieu de Mont­
real, Montreal, Que.
JChef du departement de chirurgie, Hotel-Dieu 
de Montreal.
Depuis 1962, un nouveau programme 
therapeutique a ete mis a l’essai, base sur 
les nouveaux moyens de radiotherapie et 
l’utilisation de la transposition colique ou 
gastrique pour reconstruire la continuite 
oesophago-gastrique.
Le present travail porte sur la serie de 
malades traites depuis 1962, dans le but 
d’evaluer la valeur de la conduite thera­
peutique actuelle.
Materiel Clinique
De 1962 a 1969, 75 nouveaux cas de 
cancer de l’oesophage ont ete vus a l’Hotel- 
Dieu de Montreal et servent de base a 
cette etude retrospective (tableau I). Notre
TABLEAU I.—L ocalisation  d e s  L e s io n s , 
S e x e  e t  A ge
Tiers
Tiers
superieur
Tiers
moyen
inferienr 
et cardia Total
Nombre de cas 10 39 26 75
Hommes 7 38 21 60
Femmes 3 1 5 9
Age moyen 70.1 64.9 58.8 63.5
serie comporte sept fois plus d’hommes que 
de femmes. Pour les tumeurs du tiers supe- 
rieur de l’oesophage, cependant, ce rapport 
n’est que de trois pour un. Les deux tiers 
des malades etaient dans la cinqnieme et 
la sixieme decades et Fage moyen au mo­
ment du diagnostic etait de 63.5 ans.
La ligne de conduite en ce qui a trait au 
traitement des malades operables fut la 
suivante: pour les tumeurs du tiers infe- 
rieur de l’cesophage ou du cardia, l’oeso- 
phago-gastrectomie avec reanastomose di- 
recte fut pratiquee, sans radiotherapie; 
pour les lesions situees au tiers superieur 
ou moyen, une derivation par transposition 
colique ou gastrique etait faite en premier 
lieu, suivie de radiotherapie au cobalt; 
apres un delai de trois mois ou plus, l’oeso- 
phagectomie etait envisagee, si la lesion 
avait montre un arret de sa progression 
avec la radiotherapie.
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R esultats
C’est le tiers moyen de l’cesophage qui 
est le plus souvent atteint, dans notre serie, 
avec 39 cas, suivi du tiers inferieur et du 
cardia avec 26 (tableau I). La maladie sur- 
vient a un age un peu plus jeune au tiers 
inferieur, alors que les malades atteints de 
lesions du tiers superieur sont souvent ages 
de plus de 70 ans (age moyen: 70.1 ans).
L’epithelioma epidermoide est de loin 
le plus frequent a tous les niveaux et tota­
lise plus des deux tiers des cas (tableau 
II). L’adenocarcinome, rencontre a 10 oc-
TABLEAU I I .— T ypes H isto lo c iq u e s  e t  
M e ta sta ses
Tiers
superieur
Tiers
moyen
Tiers 
inferieur 
et cardia Total
Epidermoides 7 30 Hi 53
Ad6nocarcinomes 0 1 9 10
Indifferencies 2 2 1 5
Melanome 0 i 0 1
Inconnus 1 5 0 G
Presence de 0 16 18 40
metastases (60%) (40%) (70%) (53%)
casions, origine presque toujours au cardia. 
Nous n’avons observe qu’un seul cas d’ori- 
gine oesophagienne, au tiers moyen. Cinq 
autres tumeurs etaient de type indifferen- 
cie et chez six malades le diagnostic histo- 
logique n’a pas ete etabli. Nous avons eu 
un cas de melanome du tiers moyen de 
I’oesophage. Des metastases ganglionnaires 
ou viscerales ont ete demontrees dans plus 
de la moitie des cas. C’est avec les lesions 
du tiers inferieur et du cardia qu’elles 
etaient les plus frequentes (70%). Seuls 
les ganglions etaient envahis chez 29 
malades, sept autres avaient en plus des 
lesions metastatiques hepatiques ou pul- 
monaires et dans trois cas les metastases 
etaient generalisees.
TABLEAU II I .— T r a it e m e n t
Nombre de 
cos
Aucun traitem ent 18 (24%)
Radiotherapie seule 21 (28%)
Chirurgie seule 19 (25%)
Chirurgie et radiotherapie 17 (2.3%)
A cause de leur maladie trop avancee, 
17 patients n’ont rear aucun traitement 
autre que des dilatations cesophagiennes ou 
une gastrostomie dans quelques cas. Un
autre malade a refuse tout traitement 
(tableau III). La radiotherapie fut em­
ployee dans 21 autres cas juges inope- 
rables, en association parfois a des dilata­
tions ou une gastrostomie. Parmi ces deux 
groupes de malades, l’inoperabilite fut 
constatee a l’exploration chirurgicale chez 
12. Trente-six malades (48%) ont ete 
soumis a un traitement chirurgical; la 
radiotherapie y fut associee pour 17 d’entre 
eux.
L’cesophago-gastrectomie avec anasto­
mose oesophago-gastrique fut employee 
chez 18 malades, porteurs de lesions du 
tiers inferieur ou du cardia, a 1’exception de 
deux cas ou la tumeur siegeait au tiers 
moyen (tableau IV). La radiotherapie post-
TABLEAU IV.—T r a it e m e n t  C h ir u r g ic a l
Nombre 
de cas
Presence de 
metastases 
ganglionnaires
(Esophago-gastrectomie 18* 12
CEsophagectomie et
derivation par tube 71 2
gastrique 2
colique 5
Derivation seule par tube l i t 3
gastrique 2
colique 9
*Radi'jt-h6rapie p is to p e ra to ire : un cas; chez un 
malade, deuxieme resection pour reeidive e t recon­
struction avec un tube colique gauche. 
fTous ont eu de la radiotherapie associee, sauf un 
cas.
operatoire fut associee a une seule reprise. 
Un de ces malades a du etre reopere deux 
ans plus tard pour une reeidive. Une nou- 
velle resection fut faite et un tube colique 
employe pour la reconstruction.
Pour 16 cas de tumeur du tiers moyen, 
le programme chirurgical en deux temps 
associee a la radiotherapie fut entrepris. 
Dans un premier temps, nous avons pro- 
cede a la derivation oesophagienne, a l’aide 
d’un tube colique en position retro-sternale 
a 12 reprises, d’un tube gastrique pour 
quatre autres. Tous ces malades ont ete 
ensuite soumis a la radiotherapie. Apres un 
delai de trois mois ou plus, I’cesophagec- 
tomie fut tentee chez sept d’entre eux et 
la resection fut possible dans cinq cas 
(31%). Les autres malades etaient decedes 
ou devenus inoperables.
Chez un malade, une tumeur du tiers 
inferieur fut resequee et la reconstruction
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TABLEAU V.— M o b b id itb  e t  M o r ta lite  O p e r a t o ir e s
Transpositions coliques (Esophagectomies 
(Esophago-gastredomies ou gaslriques (deuxibme temps)
Nombre de cas 18
Mortality opdratoire 2
Complications operatoires 
fistules cervicales 
fistules abdominales
2
fistule thoracique 
stenose du tube 
occlusion intestinale
1
6ventration 
ischemie du tube 
Duree moyenne
25
1
d’hospitalisation (jours)
oesophagienne faite avec un tube colique 
en un seul temps. Une autre malade fut 
soumise a Fexerese dune tumeur du tiers 
superieur et la continuity oesophagienne fut 
retablie par anastomose directe. Deux ans 
plus tard, on a du proceder a une deriva­
tion par tube colique a cause d une stenose 
oesophagienne, sans recidive de la maladie.
En tout, 11 patients n’ont pu benificier 
que d’une derivation oesophagienne suivie 
de radiotherapie, alors que pour sept autres 
la resection oesophagienne fut possible.
II y avait de l’envahissement ganglion- 
naire dans la piece chirurgicale de 17 de 
ces 36 malades. C’est dans les lesions du 
tiers inferieur et du cardia que l’incidence 
d’envahissement etait la plus forte (deux 
tiers des cas).
La mortalite operatoire fut de 11% pour 
Foesophago-gastreotomie, 10% pour la 
transposition colique et nous avons eu un 
deces parmi sept cesophagectomies (tableau 
V). Les complications operatoires furent 
particulierement nombreuses avec les trans­
positions coliques et gastriques. Cinquante- 
sept pour cent de ces cas ont presente une 
ou plusieurs complications, la plus fre- 
quente etant la fistule cervicale ou ab- 
dominale. La fermeture spontanee de ces 
fistules fut cependant la regie. Une stenose 
du tube est survenue a trois reprises, tou- 
jours sur un tube gastrique, dont Fun a 
du etre revise. Un tube colique gauche s’est 
infarci en cours d’intervention et on a du 
proceder a la transposition d’un nouveau 
tube a l’aide du colon droit. La morbidite 
operatoire pour l’oesophago-gastrectomie et 
l’oesophagectomie fut nettement plus faible: 
12% des malades seulement ont presente 
une complication. La duree moyenne de 
l’hospitalisation des malades soumis a une
19 7
2 1
11
6
3
1
3
2
1
1
66
oesophago-gastrectomie fut presque trois 
fois plus courte.
Des 18 malades non traites, un seul a 
survecu un an et la survie moyenne fut de 
quatre mois (tableau VI). La radiotherapie 
employee seule a 21 reprises a donne deux 
survies d’un an (10%) et une survie de 
deux ans (5%), mais la survie moyenne du 
groupe ne fut que tres peu affectee (5.5 
mois). La meme survie fut obtenue lors- 
que la radiotherapie fut associee a une 
derivation oesophagienne, sans que le 
traitement soit complete par Fexerese de la 
tumeur. Aucun de ces neuf malades n’a 
vecu un an apres l’intervention. L’un d’eux 
est decede d’une hemorragie oesophagienne 
secondaire a une cirrhose, au cours de la 
radiotherapie. A l’examen histologique de 
l’oesophage, on n’a retrouve aucune trace 
de cancer residuel. Tous les autres malades 
de ces trois groupes sont decedes, de leur 
maladie.
TABLEAU V I.—Survies
SurvieNombre moyenne* Survies de
Traitement de cas (mois) 1 an 2 ans 5 ans
Aucun 18 4 1 0 0
Radiotherapie 
Derivation et
21 5.5 2 1 0
radiotherapie
CEsophagogas-
9 5.5 0 0 0
trectomie 
Derivation, 
resection et
16 10.5 3 1 1
radiotherapie 6 13 i 1 2
*Patients dec6des seulement.
Les seules survies a long terme furent 
obtenues lorsque la resection oesophagienne 
a pu etre realisee. De ces 22 malades, on 
compte trois survies de plus de cinq ans 
(14%), deux de deux ans et quatre autres
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d’un an pour un total de 23% et 41% 
respectivement. Parmi les 16 malades sou- 
mis a une cesophago-gastrectomie, la piece 
chirurgicale montrait une atteinte gang- 
lionnaire chez 10. Quatorze sont mainte- 
nant decedes apres une survie moyenne de 
10.5 mois. Trois des cinq survivants plus 
d’un an apres la chirurgie ne presentaient 
pas de metastases ganglionnaires. Le seul 
malade qui a regu de la radiotherapie post- 
operatoire a survecu un an. Deux patients 
sont encore vivants, 19 mois et cinq ans 
apres l’intervention. Des six malades sou- 
mis d’abord a une derivation cesophagienne 
suivie de radiotherapie et qui ont survecu 
a la resection oesophagienne faite dans un 
deuxieme temps, trois sont encore vivants, 
deux, cinq et sept ans apres leur operation. 
La survie moyenne des trois autres fut de 
13 mois, dont une survie de plus d’un an. 
Aucun des malades vivants n’avait de meta­
stases ganglionnaires lors de la chirurgie.
De l’ensemble des malades soumis a la 
resection oesophagienne en association a la 
radiotherapie, cinq etaient libres de metas- 
tase et d’extension extra-oesophagienne a 
l’operation: 80% ont survecu plus dun an 
(quatre patients), 60% plus de deux ans 
(trois patients) et 40% sont vivants apres 
une evolution de plus de cinq ans (deux 
patients).
D iscussion
Des 75 malades souffrant d’un cancer 
oesophagien que nous avons vus au cours 
des sept dernieres annees, quatre pour cent 
seulement ont vecu plus de cinq ans apres 
que le diagnostic fut pose. Selon Naka- 
yama en 1967,7 on ne retrouvait alors dans 
la litterature que 301 cas ayant survecu 
cinq ans. La principale cause de cette mor­
tality elevee est le retard que met la ma- 
ladie a se manifester cliniquement. Le 
diagnostic est alors souvent pose lorsque 
la lesion a deja depasse tout espoir d’un 
traitement curatif. La resection ne fut pos­
sible que pour un tiers de nos malades. Le 
taux de resection generalement rapporte 
varie de 30% a 40%.'■ 3-8-11 De plus, 
meme la ou la resection est possible, des 
metastases ganglionnaires sont tres souvent 
retrouvees a l’examen de la piece chirurgi­
cale et demontrent que la maladie est plus 
avancee qu’on l’avait d’abord cru. Si, a
ceci, on ajoute 1’age avance de la plupart 
de ces malades et les sequelles d’ethylisme 
chronique chez plusieurs, on a le contexte 
clinique suffisant pour expliquer des resul- 
tats decevants.
De toute evidence, le premier pas vers 
une amelioration du taux de survie est un 
diagnostic plus precoce. Tout patient d’age 
a presenter une tumeur maligne de l’oeso- 
phage devrait etre completement investigue 
au moindre soupgon: examen radiologique 
et endoscopique de l’oesophage, accom- 
pagne d’une biopsie s’il y a lieu.
A cote du grand nombre de malades 
d’emblee inoperables, la chirurgie d’exe- 
rese, lorsqu’elle est possible, ne donne en­
core que des resultats limites pour ce qui 
est des survies a long terme. La radio­
therapie employee comme seul traitement, 
meme si elle prolonge la survie de quelques 
mois, n’a en general apporte que de rares 
survies de cinq ans. En 1965, Parker 
et Gregorie12 rapportaient une survie 
moyenne de 5.2 mois apres radiotherapie, 
sans survie de cinq ans. Moseley9 obtenait 
une survie de 12 ans, mais la moyenne 
pour 26 cas etait de six mois. La radio­
therapie nous a donne des resultats du 
meme ordre, sans survie au-dela de deux 
ans. Par contre, dans une serie de 1870 cas 
presentee par Pearson en 1969,13 les resul­
tats de la radiotherapie etaient superieurs 
a ceux de la chirurgie, avec des survies de 
cinq ans de 20% et 11% respectivement.
En 1964, Nakayama14 publiait son expe­
rience avec la radiotherapie pre-operatoire 
associee a la chirurgie. Ce traitement lui 
avait permis d’atteindre une survie de trois 
ans de 44.4% comparativement a 6.8% 
avec la radiotherapie et 21.7% avec la 
chirurgie seule. Chez sept malades, libres 
d’atteinte ganglionnaire et soumis au traite­
ment combine, la survie etait de 100%. 
Selon lui, l’irradiation pre-operatoire de 
2000 k  3000 rads avait permis un meilleur 
taux de resection en diminuant le volume 
de la tumeur et reduit la dissemination per- 
operatoire des cellules malignes. Ces pre­
miers resultats encourageants ont entraine 
l’adoption de ce programme therapeutique 
par plusieurs autres depuis lors.11- 1519 Une 
amelioration de la survie a long terme a 
ete constatee.18' 19 Goodner16 a note un 
meilleur taux de resection et, dans sept cas,
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la disparition de la tumeur cesophagienne 
apres radiotherapie.
Depuis 1962, nous avons aussi adopte 
ce traitement combine pour les lesions des 
tiers superieur et moyen. Chez cinq ma- 
lades ainsi traites et libres de metastases, 
nous avons obtenu deux survies de plus de 
cinq ans et un troisieme patient est encore 
vivant apres une evolution de plus de deux 
ans. Malgre le petit nombre de cas, ces 
resultats sont favorables, puisqu’ils repre- 
sentent presque les seules survies a long 
terme que nous avons pu obtenir dans le 
traitement de cette maladie.
Pour les lesions du tiers inferieur et du 
cardia, l’accessibilite de la lesion et la re­
construction simultanee plus facile nous 
ont fait opter pour l’exerese chirurgicale 
immediate, sans avoir recours a la radio­
therapie pre-operatoire. Meme si la survie 
moyenne fut ainsi prolongee de deux fois, 
comparativement aux malades non traites 
ou a ceux qui n’ont regu que la radiothe­
rapie, nous n’avons obtenu qu’une seule 
survie de cinq ans parmi 16 malades. Si la 
resection est le plus souvent possible a ce 
niveau, des metastases ganglionnaires sont 
tres frequemment presentes au moment de 
l’intervention (10 de 16 cas). Nous croyons 
toutefois l’exerese chirurgicale justifiee 
dans ces cas, vu la faible morbidite de 
l’oesophago-gastrectomie et la prolongation 
certaine de la survie. L’utilisation de la 
radiotherapie post-operatoire est suscep­
tible d’ameliorer ces resultats et devrait 
etre consideree dans tous les cas.
Le probleme des lesions oesophagiennes 
situees a un niveau plus eleve est bien 
different. Les metastases ganglionnaires 
sont moins frequentes parmi les cas juges 
operables (cinq de 19), mais le taux de re­
section est de beaucoup inferieur et n’atteint 
pas 50% de ces cas. La plupart des 
malades decedent au cours de la radio­
therapie, apres avoir subi une derivation 
oesophagienne. En plus de la morbidite 
tres elevee qui accompagne la transposi­
tion colique ou gastrique, celle-ci n’ame- 
liore aucunement la survie du malade si 
une resection cesophagienne ne peut etre 
faite. Meme si la transposition colique 
donne de bons resultats fonctionnels a long 
terme, surtout lorsqu’utilisee pour des 
lesions benignes, c est aussi Fexperience de
plusieurs que cette technique est taxee de 
complications frequentes et nombreuses.20-23
La valeur palliative de la derivation 
cesophagienne apparait done tres discu- 
table. Bien que certains auteurs recom- 
mandent Futilisation de la transposition 
colique a titre palliatif,24- 25 nous ne 
croyons pas que les resultats obtenus dans 
la plupart des series et dans la notre justi- 
fient cette attitude. Selon Duvoisin, Ellis et 
Payne,26 le tube de Celestin permet une 
palliation tres satisfaisante, avec peu de 
complications, tout en evitant au malade 
une intervention majeure. Guernsey, Knud- 
sen et Mark27 recommandent une lapara- 
tomie exploratrice et la biopsie des gang­
lions coeliaques pour aider a preciser l’indi- 
cation operatoire. En presence d’envahisse- 
ment ganglionnaire, ils suggerent l’absten- 
tion de toute chirurgie ulterieure. Nakaya- 
ma, Orihata et Yamaguchi,7 emploient la 
meme procedure comme premier pas thera- 
peutique et y associent une gastrostomie. Le 
malade regoit ensuite une dose concentree 
de radiotherapie et Foesophagectomie, si 
elle est possible, est faite une semaine plus 
tard. Un tube externe sert alors de deriva­
tion temporaire et le remplacement oeso- 
phagien est pratique apres une evolution 
de six a 12 mois, permettant d’evaluer le 
pronostic du malade. Avec ce programme 
therapeutique, la mortalite operatoire fut 
abaissee a 2.5%, le taux de resection ame- 
liore et la survie de cinq ans de 37.5%, 
comparativement a 19.1% avec la chirur­
gie seule.
Plusieurs techniques chirurgicales peu- 
vent etre employees pour la reconstruction 
cesophago-gastrique. Belsey28 suggere l’em- 
ploi de l’oesophago-gastrostomie pour les 
lesions malignes, tandis que Nakayama, 
Orihata et Yamaguchi,7 utilisent le tube 
gastrique ante-thoracique. Staley et Scan­
lon,29 discutant des diverses techniques de 
remplacement, favorisent le tube colique. 
C’est cette derniere qui est actuellement la 
plus employee20, 21> 24’ 25’ 30 et que nous 
avons aussi adoptee, avec des resultats 
fonctionnels satisfaisants. Plus important 
encore que la technique a utiliser, Fana- 
tomie et Fintegrite vasculaires du segment 
a transposer doivent etre inspectees atten- 
tivement de fagon a s’assurer a Favance 
d’une irrigation sanguine adequate.
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Conclusion
II ne fait aucun doute que la radiothe- 
rapie associee a la chirurgie a ameliore le 
pronostic des malades atteints de cancer 
de l’oesophage, lorsque la lesion peut etre 
resequee et qu’i] n’y a pas d’atteinte gang- 
lionnaire. Son utilisation etendue aux 
lesions du tiers inferieur peut laisser 
esperer la aussi de meilleurs resultats. Par 
ailleurs, un diagnostic plus precoce s’im- 
pose, si on veut parvenir a un taux de 
resection superieur et diminuer l’incidence 
des metastases ganglionnaires. Pour le 
malade inoperable, il faut envisager une 
palliation qui permettra une alimentation 
adequate, tout en ne comportant qu’une 
faible morbidite, vu la courte duree de la 
survie. La derivation oesophagienne par 
transposition colique ou gastrique ne pro- 
longe aucunement la survie et, a cause de 
ses complications trop nombreuses, ne peut 
etre consideree comme une methode pal­
liative satisfaisante. La prothese de Celes- 
tin, par contre, offre l’avantage d une mor­
bidite moindre et semble donner de bons 
resultats. La radiotherapie peut generale- 
ment offrir quelques mois de vie de plus a 
ces malades. L’exploration abdominale et 
la biopsie des ganglions coeliaques est un 
autre rnoyen recommande pour preciser 
l’indication operatoire et le pronostic du 
malade, avant d’entreprendre une chirurgie 
extensive, et elle devrait etre envisagee 
pour les lesions des tiers moyen et supe­
rieur de 1’oesophage.
Resume
Nous avons analyse les resultats thera- 
peutiques chez 75 nouveaux cas de cancer 
de l’oesophage vus a l’Hotel-Dieu de Mont­
real, de 1962 a 1969. Cinquante-deux pour 
cent des malades n’ont regu aucun traite- 
ment ou seulement de la radiotherapie. Les 
survies moyennes furent respectivement de 
quatre et 5.5 mois, sans survie de cinq ans. 
Quarante-huit pour cent ont subi un traite- 
ment chirurgical et la radiotherapie y fut 
associee chez pres de la moitie. La deriva­
tion oesophagienne palliative n’a pas pro- 
longe la survie des patients, alors que la 
resection oesophagienne a permis d’obtenir 
une survie moyenne plus de deux fois plus 
longue que celle des autres groupes de 
malades et a donne les seules survies de
cinq ans de toute la serie. Des cinq ma­
lades, libres de metastases, qui ont regu de 
la radiotherapie et subi une derivation 
oesophagienne, puis une cesophagectomie, 
quatre ont survecu un an et deux sont 
vivants apres une evolution de plus de cinq 
ans. Le diagnostic precoce est un element 
essentiel au pronostic de ces patients et 
Fexploration abdominale peut permettre un 
choix plus judicieux des candidats a un 
traitement chirurgical. La derivation oeso­
phagienne par transposition colique com- 
porte un taux eleve de complications et, de 
ce fait, ne s’avere pas une methode pallia­
tive recommandable.
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Summary
The results of treatment of 75 new patients 
with esophageal cancer seen at the Hotel-Dieu 
Hospital, Montreal, between 1962 and 1969, are 
presented. Thirty-nine (52%) patients received no 
treatment, or radiotherapy only. The average 
survival time was four and 5.5 months respec­
tively with no five-year survival. Thirty-six (48%) 
patients were treated surgically and almost half 
of these received radiotherapy. Palliative eso­
phageal replacement did not increase the survival 
time; with esophageal resection (three five-year 
survivors) survival was more than twice as long 
as that observed among the other groups of pa­
tients. In five patients, free of metastasis, who 
were treated with radiotherapy and esophageal 
replacement, followed by esophagectomy, four 
survived one year and two are still alive more 
than five years after operation. The authors stress 
the importance of an early diagnosis; abdominal 
exploration may allow a better choice of patients 
to be submitted to further operative treatment. 
Esophageal replacement by colon interposition is 
attended by too many complications to be recom­
mended as a standard palliative procedure.
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ACID-BASE CHANGES IN PATIENTS WITH INTRACTABLE PAIN
AND MALIGNANCY*
R. J. EVANS, M.R.C.S.[Eng.], C.R.C.S.[C],t Toronto, Out.
Intractable pain is a subjective phe­
nomenon associated with a great variety of organic and psychiatric states. At the Irene 
Eleanor Smythe Pain Clinic in Toronto, 80% of patients referred to us have intract­
able pain associated with advanced malig­
nancy. These clinics, which have been held regularly each week at the Toronto 
General Hospital, Princess Margaret Hospi­tal and Queen Elizabeth Hospital since 
1966, were established to study the causes and management of intractable pain in the 
expectation that treatment might be much improved by a systematic and careful 
study and evaluation. It was recognized 
that any individual doctor or specialty group saw only a few patients with in­
tractable pain and that each tended to apply particular techniques to the prob­
lem. The Clinic was regarded as a mechan­ism to bring together a sufficient number 
of patients, focus on their problems, and study these problems in depth. Many pa­tients obtain relief of pain using orthodox 
treatment, including analgesics—combined with tranquilizers, steroids, radiotherapy, 
chemotherapy, neurosurgical procedures, 
and local nerve blocks. Most patients 
with advanced malignancy do not present 
with intractable pain, in spite of clinical 
and radiologic evidence of disseminated 
malignancy, and it is often difficult to 
understand why one group should have 
pain and the other not. Furthermore, 
we do not understand how traditional 
forms of therapy relieve symptoms or even 
the mechanism of action of analgesics. The 
purpose of this report is to record our ob­servations of acid-base changes associated 
with varying degrees of pain associated 
with malignancy.In 1968 I made the chance observation that people with intractable pain associ-
0 From the Departments of Surgery and Anes­thesia, University of Toronto, Toronto General Hospital and The Princess Margaret Hospital, Toronto, Ont.
fDirector of the Irene Eleanor Smythe Pain Clinic; Research Associate, Department of Sur­gery, University of Toronto.
ated with advanced malignancy had 
carbon-dioxide combining powers (C 0 2 cp.) in the upper range of normal, and very often above normal, but when the 
pain was relieved, by whatever technique, 
the C 02 cp. returned to the middle and 
often the lower range of normal. At that 
time a retrospective study of 175 such pa­tients at the Irene Eleanor Smythe Pain 
Clinic showed an apparent linear relation­
ship between the C 0 2 cp. and subjective severity of the pain. On the strength of 
this, a prospective study was set up to determine the acid-base balance in 91 pa­
tients with malignancy and pain, by esti­mating the arterial pH and blood gases.
M ethod of Study
Patients are referred to the Pain Clinic for many reasons, including opinions on 
the etiology, severity, disability caused by the pain, observation of results of treat­
ment, and for recommendations regarding management of pain. The pain is clinically 
assessed by participating physicians, in­cluding radiotherapists, anesthetists, mem­
bers of all the surgical subspecialties, in­
ternists and general practitioners.
The severity of pain is recorded in the 
patient’s own words and, if the patient can­not describe the severity of his pain, an 
objective assessment is made, based upon 
the following criteria: mild pain—that
which allows a patient to participate in 
normal social and occupational activities; 
mild to moderate—pain that usually allows 
normal social and occupational activities, 
but intermittently keeps the patient at home; moderate—that which keeps the pa­
tient at home, unable to participate in social and occupational activities; moderate to severe—pain that keeps the patient at 
home, requiring periods of rest; severe— that which confines the patient to bed for the greater part of the day, but allows toilet privileges; very severe—pain that confines the patient to bed at all times, and precludes any movement; intractable- 
pain that has been present for more than
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one month without remission, in spite of 
treatment.
Patients were screened clinically by 
taking detailed histories, and radiologi- 
cally, for pulmonary, renal and metabolic 
abnormalities that might materially alter 
the acid-base status. No drugs were 
allowed for at least four hours before the 
investigation, and the patient rested for at 
least 20 minutes before the blood sample 
was drawn.
The severity of pain was subjectively 
assessed, and simultaneously femoral arte­
rial blood was sampled anaerobically, 
using heparinized, standard, sterile, plastic 
syringes and disposable needles. Samples 
were immersed in ice and transported to 
the laboratory for study within one-half 
hour. The pH and blood gases were esti­
mated under routine laboratory conditions, 
using the radiometer method at Toronto 
General Hospital and the Instrumentation 
Laboratory technique at the Princess Mar­
garet Hospital. Using the hemoglobin, arte- 
rial pH, and carbon-dioxide tension (PC 02), 
the total carbon dioxide (TCCL), and the 
base excess or deficit (B E )  were calcu­
lated, using a Sigaard-Andersen nomo­
gram.1 At the same time, a blood sample 
was taken for hemoglobin and serum elec­
trolytes, including serum calcium estima­
tion.
At the initial assessment of the 91 pa­
tients, 21 had no pain and 70 had varying 
degrees of pain. We saw many more pa­
tients with severe and very severe pain, 
but excluded them from our study, because 
of other metabolic disturbances associated 
with advanced disease, e.g. uremia, drain­
ing fistulas, vomiting, or diarrhea. Of these 
91 patients, 10 obtained remission of their 
pain with conventional forms of treatment, 
10 continued to have pain in spite of treat-
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Fig. 1.—Calculated base excess or deficit from 
the first sample of arterial blood taken from 91 
patients with varying degrees of pain.
ment, and seven patients had increasingly 
severe pain.
We did not take further arterial samples 
from the remaining 64 patients, for various 
reasons, e.g. medication having been taken 
within four hours of consultation, the ad­
ministration of blood transfusions or intra­
venous therapy, the inadvisability of arte­
rial punctures, the patient coincidentally 
consuming antacids, the onset of hyper­
calcemia, renal failure, vomiting because 
of protracted constipation induced by 
drugs, or simply inability to attend the 
outpatient department because of disability
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TABLE I.— I n itia l  pH and B lood-G as M ean  V a lu es  fo r  91 P a t ie n t s  E x p e r ie n c in g  
V aryin g  D e g r e e s  of P ain
No. of 
patients
pH PCOj TCO> BE
Pain severity M* SD A/f SD M* SD M* SD
No pain 21 7.400 ±  .053 37.5 ±  5.1 24.4 ±  4 .3 — 1.4 ±  3.0
Mild and mild-moderate 
Moderate and moderate-
33 7.455 ±  .043 37.2 ±  4 .5 26.8  db 2.2 2 .4 ±  1.8
severe 30 7.460 ±  .046 40.7 ±  5 .5 29.6  ±  3.2 4.7 ±  2.8
Severe and very severe 7 7.490 ±  .049 38.8 ±  5 .9 30.1 ±  5.1 5.7 ±  4.2
*P <  0 .01 ; |P <  0 .05 ; M = mean; SD = standard deviation.
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TA BLE I I — C hanges in  Acid- B a se  S t a tu s  A sso cia ted  W ith  C h an g es in  P ain  S e v e r it y
pH Pt'O, TCO j B E *
Conventional treatment: 
Decreased pain— 10 
patients
Before
After
7 .466 
7.443
39.8
37.3
29.4
26.5
4 .8
1.5
Increased pain—7 
patients
Before
After
7.424
7.479
40.3
39.3
27.3
30.0
1.9
4 .3
Supplementary aceta- Before 7.462 40.9 28.8 4 .8
zolamide with decreased
pain— 10 patients After 7.414 34.3 23.2 —2 .0
*P <  0.01.
or the distance involved. These patients 
were subsequently excluded from further 
research investigation.
R esu lts
Arterial Blood Values
Mean values for the initial estimated pH 
and blood gases in the 91 patients are 
shown in Table I, and a scatter plot of the 
absolute base excess or deficit values in 
Fig. 1. Both indicate that the measured 
(pH and P C 02) and calculated (T C 0 2 
and B E ) values increase progressively with 
the increase in pain.
Analysis of variance showed that, for all 
variables, real differences exist among the 
mean values for the various pain cate­
gories. The F ratios for the comparison of 
the differences among the means were 
largest for TCO, (12.03) and BE (25.30), 
indicating that these calculated values dif­
ferentiated more clearly between the pain 
categories than the measured quantities, 
and suggesting that differentiation was 
similar for these variables, e.g. base excess 
of + 5 .7  indicates acid-base status more 
clearly than knowing the pH is 7.49 and 
P C 02 38.8.
Table II shows changes in BE in those 
patients whose pain was relieved with the 
use of conventional forms of therapy. The 
reduction in severity of pain was generally 
accompanied by a reduction in BE. Fig. 2b 
shows the data for base excess in seven 
patients who had increasing pain in spite 
of large frequent doses of morphine, and 
each of these had a progressive increase in 
the base excess (Table II, Fig. 2c), cor­
responding consistently with the relation­
ship shown in Fig 2a.
The 10 patients who continued to have 
pain after conventional therapy were each 
given supplementary acetazolamide (Dia-
mox), and all had a decrease in the 
severity of pain. Fig. 2d and Table II show 
the concomitant reduction in BE, and the 
pattern of change also corresponds with 
the relationship shown in Fig. 2a.
D iscu ssio n
Ninety-one patients in this study had 
varying degrees of metabolic alkalosis pro­
portional to the severity of the pain. Pa­
tients with advanced malignancy, who did 
not have any pain, did not have acid-base 
changes. When the patients who originally 
had pain were relieved of it, the metabolic 
alkalosis was relieved. The addition of 
acetazolamide to the treatment of those 
who continued to complain of pain ame­
liorated the symptom. Thus, the relief of 
metabolic alkalosis might be of consider­
able importance in the management of in­
tractable pain. The precise physiologic 
significance of the alkalosis associated with 
pain is not immediately apparent, but ap­
pears to warrant further investigation.
Twenty per cent of patients with ad­
vanced malignancy have metabolic alka­
losis,2 but to date no one has correlated 
acid-base balance with the degree of pain. 
However, several workers have reported 
the relationship between elevated P C 0 2 
levels and head pains at high altitude.8
Metabolic alkalosis occurs in patients 
who consume large quantities of bicarbo­
nate, and those who have renal disease and 
are dehydrated. The symptoms—mild 
gastric complaints ( a distaste for food, 
especially milk, intermittent nausea, vomit­
ing and occasional abdominal pain) and 
mood changes, including introspection, 
irritability, and nervousness—may appear 
in a few days, but commonly take a num­
ber of weeks to develop.4
As the alkalosis becomes more severe.
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Fig. 2.—Patterns of calculated base values in relation to subjective severity of pain.
the patient may complain of headaches, 
dizziness and lightheadedness. Neuro­
muscular disturbances attributed to the 
reduction of the ionized calcium may 
produce myalgia, muscle spasms and, oc­
casionally, tetany. Other signs that may 
accompany progressive alkalosis include 
low-grade fever, tachycardia, slow respira­
tions, a flushed face, hyperesthesia and 
hyper-reflexia. If untreated, metabolic alka­
losis causes progressive weakness and
prostration, and eventually coma and death 
due to the alleged nephrotoxic effect of 
prolonged metabolic alkalosis.4 Patients 
with intractable pain associated with 
malignancy have many of these signs and 
symptoms.
Ayers and Grace5 recently described in­
tractable cardiac arrhythmias associated 
with alkalemia, and Agostoni, Podda and 
Signoroni6 pointed to the possible signifi­
cance of alkalosis in stress. Adler, Roy and
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Reiman7 have reported that all degrees of 
extracellular alkalosis produce alkaliniza- tion of cells, despite compensatory changes in PC02 and extracellular bicarbonate con­centration, but acidification appears to 
have no discernible effect on cell pH until the PC02 rises above 70 mm. Hg, or inter­
stitial fluid bicarbonate falls below 7 mEq./l. In acute pain, hyperventilation is 
common, whereas in intractable pain, in 
our experience, hyperventilation is rare. Voluntary hyperventilation produces a 
gross increase in blood pH within a few 
minutes and reduces the plasma bicarbo­
nate.8 Ayers and Grace5 coined the term 
“inappropriate pulmonary ventilation in the critically ill” to emphasize that either 
hypoventilation or hyperventilation may 
interfere with physiologic processes, and to remind clinicians to treat the underlying cause rather than continue to use in­
appropriate drugs. According to Severing- 
haus et al.,8 the blood-cerebrospinal fluid (CSF) barrier responds to the initial 
hyperventilation alkalosis of acclimatiza­tion to altitude by actively reducing the 
CSF-bicarbonate ion, and Giacobini9 has 
reported that glia, like choroid plexus, is rich in carbonic anhydrase. These facts led 
us to ask what changes chronic metabolic 
alkalosis associated with intractable pain might induce in neurocellular integrity, 
enzymatic function and ion exchanges.
According to Shenkin,10 patients with 
organic pain have an abnormal diurnal 
variation of plasma cortisol, and he sug­
gested that the pituitary adrenocortical 
secretion might respond differently under 
the primitive stimulus of somatic pain. 
Stanbury and Thomson11 described a regu­
lar diurnal urinary excretion pattern in 
healthy adults, in which the bicarbonate 
excretion in the evening and when asleep 
is lower than that on waking and in the 
early part of the day. In our patients we 
found a persistent paradoxical acid urine, 
and the acid-base disturbances we observed 
suggest that we might be able to correlate 
the more severe nocturnal pain with fluc­
tuations in bicarbonate levels.
In World War II, Beecher12’ 13 reported that many extensively injured men did not experience severe pain, and offered several 
explanations for this phenomenon. Clou­
tier, Lowery and Carey14 emphasized that humans with hemorrhagic traumatic shock suffer a wide spectrum of acid-basc distur­bances and showed that some degree of metabolic acidosis is common but that, in many, the acid-base balance may be nor­mal, or “even alkalotic”. Unfortunately, 
Beecher did not know the acid-base status in his patients who did not have pain and 
were not in clinical shock. These observa­tions raise the question: does the metabolic 
acidosis accompanying hemorrhagic shock 
induce some degree of analgesia?
In 1948, at a symposium on the treat­
ment of painful disorders of skeletal muscle,15 when asked why she included 
ammonium chloride in the list of anal­
gesics, Dr. Janet Travell answered: “In the 
occasional case, dramatic relief of pain is 
secured by the oral administration of am­monium chloride, 0.5 to 1.0 g., three times 
a day. The mechanism is unknown, but it might depend on the production of a 
diuresis and withdrawal of fluid from the muscles.” Aspirin compounds and opiates, 
probably the most widely used analgesics, induce acidosis, alter the mood and relieve pain for varying intervals, yet in a minority 
of patients in normal therapeutic dosages, they may be completely ineffectual.
In a few patients with pain refractory 
to conventional therapy, we attempted to 
reduce the base excess with acetazolamide 
(Diarnox), and thus reduce analgesic re­
quirements and more effectively control 
the pain. In these patients the improve­
ment does not occur dramatically, and pain 
continues on movement of areas where 
there is gross skeletal destruction, e.g. 
pathologic fractures, but the pain at rest 
is more easily controlled. With acetazola­
mide, improvement takes 48 to 72 hours 
and is associated with a marked reduction in base excess. We are now conducting a 
prospective study to define more accurately the part played by acid-base balance in the 
intractable painful states associated with advanced malignancy.
Other groups of patients with intractable pain problems are also being studied in the same way at the Clinic, but the numbers are too small in each sub-group to validate any report of the findings to date, How­ever, in patients where no organic cause
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for pain can be determined, e.g. psychiatric 
patients, acid-base balance is normal, but 
in patients with pain and skeletal dis­
orders, e.g. rheumatoid arthritis, a similar 
metabolic alkalosis has been demonstrated. 
These observations will be reported later.
Su m m a r y
Intractable pain presents one of the most 
difficult and challenging problems in as­
sessment and management. The physio­
logic changes accompanying intractable 
pain, and mechanism of action of con­
ventional therapy are not well understood.
A study of 91 selected patients with in­
tractable pain and advanced malignancy 
showed that they have a metabolic alka­
losis proportional to the subjective severity 
of their pain. This alkalosis is corrected 
when the pain is relieved with conven­
tional treatment. When the pain continues 
unrelieved, alkalosis persists and may 
worsen. Treatment of the underlying meta­
bolic alkalosis appears to alleviate the in­
tractable nature of the pain.
These observations suggest that: intract­
able pain and pain of increasing severity 
is associated with a base excess; data on 
acid-base balance may give a reliable indi­
cation of the degree of the patient’s pain 
and may explain the absence of pain in 
severe hemorrhagic shock; the relationship 
between acid-base balance and pain may 
shed light on the action of analgesics and 
the mechanisms of intractability; treatment 
of the underlying alkalosis may aid in the 
conventional management of pain.
This study was sponsored by the Irene Eleanor 
Smythe Pain Research Fund, University of 
Toronto. The author wishes to thank Mr. Conn 
Smvthe, all participating physicians and ancillary 
staff at The Princess Margaret Hospital, Toronto 
General Hospital and Queen Elizabeth Hospital, 
and Professor W. Reid, Department of Biometrics, 
University of Toronto, for helping with the 
statistical evaluation; also Mrs. R. Topp, for her 
invaluable secretarial assistance.
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R esume
Une douleur rebelle est un des problemes les 
plus difficiles a evaluer et a traiter. On ne com- 
prend pas bien les modifications physiologiques 
qui accompagnent cette douleur rebelle, pas plus 
que le mode d’action des traitements mis en 
oeuvre pour la contrer.
Ayant choisi 91 malades souffrant de tumeur 
maligne et de douleur opiniatre, les auteurs ont 
constate qu’ils presentaient une alcalose metabo- 
lique proportionelle a Tacuite subjective de leur 
douleur. Cette alcalose est corrigee une fois que 
la douleur est soulagee par les analgesiques clas- 
siques. Si la douleur persiste, sans soulagement 
aucun, l’alcalose persiste egalement et peut meme 
s’aggraver. Le traitement de Talcalose metabolique 
sous-jacente permet d’attenuer la nature rebelle 
de la douleur.
Ces observations permettent de crone que: une 
douleur rebelle ou une douleur dont Tacuite aug- 
mente s’accompagne d’un exces de base; des ren- 
seignements sur l’equilibre  ^acide-base peuvent 
constituer une indication precieuse sur le degre 
de la douleur chez le malade et peuvent expliquer 
l’absence de douleur dans le choc hemorrhagique 
severe; la relation existant entre l’equilibre aciclo- 
basique et la douleur peut jeter quelque lumiere 
sur l’action des analgesiques et sur les mecanismes 
qui interviennent dans la douleur opiniatre; traiter 
Talcalose profonde peut faciliter le traitement de 
la douleur par les analgesiques courants.
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S IG M O ID O R E C T A L  IN T U SSU SC E P T IO N :
AN U N U SU A L R E C T A L  M ASS A SSO C IA T ED  W IT H  
H Y PO K A LEM IC  M E T A B O L IC  A LK A LO SIS
ROBERT C. MOFFAT, M.D., F.R.C.S.fC]0 and MAURICE DANIEL, M.D.,+ Trail, B.C.
Sigmoidorectal intussusception is an un­
usual condition which presents as an an­
terior rectal mass and simulates a polypoid 
lesion of the rectum. The following pre­
sentation was associated with hypokalemic 
metabolic alkalosis and, clinically, sug­
gested a villous adenoma.
Case Report
Mrs. A.F., a 57-year-old white woman, was 
admitted to the Hotel Dieu of St. Joseph 
Hospital, Windsor, Ontario, on June 30, 1968. 
For approximately 10 days before admission 
she had profuse mucous diarrhea that occa­
sionally contained gross blood. She denied 
any previous difficulties with her bowel move­
ments; they had always been regular and she 
had had no previous episodes of diarrhea or 
constipation. The family history, personal and 
functional inquiry were non-contributory.
She was seen in the emergency room be­
cause of her abdominal distension.
She was a well-developed, thin, white 
woman who had lost 4 lbs. over the past three 
months. Her blood pressure was 140/80 mm. 
Hg and her pulse was 88/min. Her admission 
temperature was 98° F. Her abdomen was 
distended and somewhat tympanitic; bowel 
sounds were normal. No abdominal masses 
were palpable and there was no evident 
tenderness or guarding. On rectal examination, 
she had moderate external hemorrhoids and a 
small perianal lipoma. Approximately two 
inches above the anal verge was a large, soft, 
irregular lesion obstructing the lumen and in­
volving the anterior rectal wall. The clinical 
impression was that of a villous adenoma 
and/or a carcinoma of the rectum.
Initial laboratory studies included: hemo­
globin 13.8 g./lOO ml.; leukocyte count 20,- 
000/c.mm. with 80% neutrophils, 10% lympho­
cytes and 3% monocytes; reticulocyte count 
1.7%; prothrombin time 14.5 seconds; Wester- 
gren sedimentation rate 34 mm. in one hour; 
alkaline phosphatase 30 King-Armstrong units; 
serum glutamic oxaloacetic transaminase 
(SGOT) 26 units/ml.; lactic acid dehydro­
genase (LDH) 310 units/ml.; indirect bilirubin
“The C. S. Williams Clinic, Trail, B.C. 
113774 St. Gregory Road, Windsor, Ont.
0.3 mg./100 ml.; direct bilirubin 0.5 mg./100 
ml.; serum sodium 130 mEq./l.; serum potas­
sium 2.5 mEq./l.; serum globulin 2.0 g./lOO 
ml.; blood urea nitrogen (BUN) 8 mg./100 
ml.; and fasting blood sugar 136 mg./100 ml. 
Urinalysis was negative for sugar, acetone and 
albumin. Stool specimens on three occasions 
were 4 +  for occult blood.
The radiograph of the chest was normal. 
Flat and upright films of the abdomen sug­
gested that there was an obstructing lesion in 
the region of the distal sigmoid colon. Electro­
cardiogram demonstrated non-specific ST-seg- 
ment changes.
On July 1, 1968 a sigmoidoscopic examina­
tion showed a large edematous friable lesion 
just above the anal verge. Several biopsies 
revealed only non-specifically inflamed rectal 
mucosa with no evidence of malignancy. Up 
until this time the patient continued to have 
profuse mucous diarrhea. Repeat films of the 
abdomen revealed some distended small-bowel 
loops and further distension of the large 
bowel. Over the next four days her tempera­
ture remained within normal limits; her hypo­
kalemic metabolic alkalosis continued. Serum 
sodium levels ranged between 133 and 135 
mEq./l., and serum potassium levels ranged 
between 1.9 and 2.9 mEq./l. During this time 
the patient was receiving a minimum of 80 
mEq. of potassium intravenously on a daily 
basis.
On July 6, seven days after admission, the 
patient’s temperature spiked to 102° F. On 
this date she had a serum sodium of 135 
mEq./l., a serum potassium of 2.5 mEq./l., 
and a chloride of 98 mEq./l. On the follow­
ing day a rectal and sigmoidoscopic examina­
tion under general anesthesia showed a large 
sausage-shaped lesion in the anterior rectal 
area which projected into the lumen of the 
rectal ampulla. For the first time, we recog­
nized that this mass might represent a sig­
moidorectal intussusception. Although the 
sausage-shaped mass was polypoid, the ex­
amining finger could be passed several centi­
metres into it through a doughnut-like depres­
sion in its centre. Through a lower midline 
incision, approximately 400 to 500 ml. of sero- 
purulent fluid was drained from the abdomen. 
This was cultured but no growth was sub­
sequently obtained. Exploration of the abdo­
men was negative except that six to eight
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inches of sigmoid colon had intussuscepted 
into the rectum. This was reduced with con­
siderable difficulty. On reduction we saw that 
the tip of the colon, which had been the apex 
of the intussusception, had become necrotic 
and had perforated at its centre. The involved 
sigmoid colon was resected and the proximal 
end brought out as an end-colostomy in the 
left lower quadrant, and the distal end was 
brought out as a mucus fistula. The patient 
tolerated this procedure quite well.
Her postoperative course was uneventful 
and approximately 2 V2 weeks later her colos­
tomy was closed under general anesthesia. At 
this time, her serum sodium level was 133 
mEq./l., serum potassium level 3.0 mEq./l., 
serum chloride level 93 mEq./l. and her 
plasma pH was 7.44. She was discharged on 
July 31 and has remained free of symptoms 
since.
D iscussion
In sigmoidorectal intussusception the 
distal sigmoid and upper rectum prolapse 
into the rectal ampulla. This may be inter­
mittent or, as in this patient, may stimulate 
a polypoid lesion of the rectum. According 
to Goligher,1 this type of intussusception 
differs from other types because it rarely 
strangulates or completely obstructs the 
bowel. He also stated that this type usually 
reduces itself spontaneously. Our experi­
ence with the patient described here con­
tradicts this; she had frank perforation 
with a seropurulent peritonitis.
Most case reports2,8 indicate that this 
type of intussusception is usually caused 
by malignant tumours. Upon pathological 
examination of the resected colon, we 
found a small benign polyp approximately 
1.5 cm. in diameter and 4 cm. from one 
end. The intussusception could have 
started at this polyp. During the examina­
tion of the resected specimen, the polyp 
was nowhere near the apex of the intus­
susception or its leading edge.
Intussusception such as this could be 
considered a form of rectal prolapse and 
consequently have the same type of patho­
genesis. W e believe that most rectal pro­
lapses are actually types of intussusception, 
as recent cineradiographic studies4 have 
demonstrated. Most of these intussuscep­
tions begin in the rectosigmoid area, per­
haps as a redundant sigmoid loop or an 
abnormally long mesosigmoid.
Profuse mucous diarrhea and blood­
stained rectal discharge are the most com­
mon symptoms in sigmoidorectal intus­
susception and also in villous adenomas. 
These patients may also have constipation 
and a dragging sensation in the pelvis. 
The telltale finding was an anterior, 
sausage-shaped, polypoid mass with a 
doughnut-like depression in its centre.
Certain large villous adenomas of the 
sigmoid colon and rectum produce pro­
found fluid and electrolyte depletion. The 
syndrome was first described by McKittrick 
and Wheelock5 in 1954. These tumours are 
also associated with profuse mucoid 
diarrhea. As is sometimes the case in pa­
tients with villous adenomas, this patient 
had a hypokalemic metabolic alkalosis, 
presumably as a result of the profuse 
mucous diarrhea. The colonic mucosa 
secretes potassium even under normal cir­
cumstances and mucus contains a con­
siderable amount of potassium ion.
Sigmoidorectal intussusception should be 
treated by an anterior resection of the 
colon. However, because of the colonic 
perforation and leakage, we elected to per­
form an end-colostomy, resect the involved 
segment, and create a distal mucus fistula.
C onclusion
An unusual case of sigmoidorectal intus­
susception has been presented. Clinically, 
the profuse mucous diarrhea, in associa­
tion with the rectal mass and hypokalemic 
metabolic alkalosis, suggested a villous 
adenoma of the rectum. The pathogenesis 
of this type of intussusception is thought 
to be the same as rectal prolapse. Sig­
moidorectal intussusception should be con­
sidered in the differential diagnosis of 
rectal masses.
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Resume
Les auteurs presentent un cas exceptionnel d’in- 
vagination sigmoidorectale. Au point de vue 
clinique, la diarrhee muqueuse abondante, as- 
sociee a la presence de la masse rectale et a 
l’alcalose metabolique hypokaliemique laissait sup-
poser qu’on avait affaire a un adenome villeux du 
rectum. On estime que la pathogenie de ce type 
d’mvagination est la meme que celle du prolapsus 
rectal. Dans tout diagnostic differentiel de masses 
rectales, il faut envisager la possibility d’une in­
vagination sigmoidorectale.
BREAST CARCINOMA 30 YEARS A FTER THOROTRAST 
MAMMOGRAPHY*
M. Y. AHMED, M.D.t and II. D. STEELE, M,D.,$ Kingston, Ont.
The development of cancer in a breast 
previously exposed to ionizing radiation is 
well recognized. Such cases have been re­
ported in atomic bomb survivors1 and in 
women who have had multiple fluoroscopic 
examinations to control pneumothoraces 
for pulmonary tuberculosis.2' 3 A rare ex­
ample of radiation-induced cancer is that 
which follows the use of Thorotrast, a col­
loidal solution of thorium dioxide used to 
visualize ducts and enclosed spaces. The 
small particle size of this medium is ideal 
for such work, but there is a radiation 
hazard because the thorium radiation con­
sists of 90% alpha, 9%  beta and 1%  
gamma rays. Since its first use by Hicken4 
to diagnose breast lesions, two cases of 
primary breast carcinoma have been re­
ported following its use, and a third case 
is reported here.
Case Report
A 60-year-old woman was admitted to 
Kingston General Hospital on November 27, 
1969, with a one-month history of soreness 
and puckering of the skin of left breast. Many 
years before she had had an occasional bloody 
discharge from both nipples during each of 
three pregnancies. During her second preg-
"From the Department of Pathology, Kingston 
General Hospital, and Queen’s University, Kings­
ton, Ont.
tResident in Pathology, Kingston General Hospital.
^Associate Professor of Pathology, Queen’s Uni­
versity; Research Associate, Ontario Cancer Treat­
ment and Research Foundation.
Fig. 1.—Mammogram of the right breast show­
ing density due to Thorotrast.
nancy in 1939, both breasts were investigated 
by Thorotrast mammography at another hos­
pital, but no significant abnormality was 
found. In 1942, a lump developed in her left 
breast and was removed in three pieces. These 
contained a number of small hard masse.1 
which were granular and yellow on the cu; 
surface. There was no evidence of neoplasm 
and the diagnosis was foreign-body granuloma 
with necrosis.
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No additional lumps were noted in her 
breasts until just before the present admission. 
At this time, the right breast was normal but 
the left breast contained a non-tender 2 x 2 -  
cm. hard mass just lateral to the nipple. A 
slightly puckered scar, the site of the previous 
biopsy, was present over it.
Bilateral mammography showed a localized 
collection of contrast medium centrally in the 
right breast (Fig. 1). There was a diffuse dis­
persal of contrast medium in the left breast 
with two areas of concentration, one on the 
medial and one on the lateral side (Fig. 2).
Fig. 3.—Roentgenogram of the left axillary area 
showing multiple densities thought to be due to 
Thorotrast in the lymph nodes.
greyish-yellow with white material scattered 
irregularly in the central portion (Fig. 4). On 
microscopic examination, the mass was largely 
fibrous with irregularly sized and placed col­
lections of refractile granular material inter­
preted as Thorotrast. Adenocarcinoma was 
present, especially about the periphery of the 
mass (Fig. 5), but also in some areas within 
it (Fig. 6). In addition, some of the small 
ducts were lined by cells with atypical nuclei,
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Fig. 4.—Cut section of the tumour of the left 
breast, showing Thorotrast as white material scat­
tered irregularly in the central portion of the 
specimen.
Fig. 2.—Mammogram of the left breast showing 
two main areas of concentration of Thorotrast, 
and also a diffuse dispersal throughout the tissue.
Both of these areas had extensive fibrotic 
changes which the radiologist related to the 
presence of the contrast medium. Lymph 
nodes in the left axilla had densities suggest­
ing Thorotrast (Fig. 3). Radiologic examina­
tion showed no evidence of this agent in the 
spleen or liver.
A left breast biopsy was done on December 
1, 1969, and a modified Halsted radical
mastectomy followed the frozen-section diag­
nosis of adenocarcinoma. A hard 3 x 3 x 1.5- 
cm. mass, found just lateral to the nipple, was 
gritty on sectioning and the cut surface was
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Fig. 5.—Photomicrograph of adenocarcinoma 
extending out into fatty connective tissue from 
the reactive fibrosis that contains the Thorotrast 
(hematoxylin-phloxine-saffron stain X 312).
suggesting at least a premalignant state. A few 
foci had plate-like refractile crystals with 
multinucleated foreign-body cells about them 
(Fig. 7). This material and the reaction to it 
was unlike the Thorotrast granules. Auto­
radiographs showed tracks characteristic of 
alpha particles (Fig. 8). The axillary lymph 
nodes had Thorotrast in and adjacent to them 
(Fig. 9), but no tumour was found.
The remaining breast was removed several 
weeks later and it had areas of fibrosis con­
taining granular material compatible with
Fig. 7.—Photomicrograph of a fibrous area of 
left breast as seen under partially polarized light. 
The Thorotrast shows as granular material (larger 
arrow) and the unidentified refractile material is 
white ( smaller arrow) ( hematoxylin-phloxine-
saffron stain, original magnification X 500).
Thorotrast but no tumour. The specimen was 
examined for gamma radiation but the amount 
was too slight to be measurable.
D iscussion
Radt5 first described the use o f Thoro­
trast to visualize the liver and spleen in 
1929. A few  years later, Selbie6 reported 
that Thorotrast produced tumours in ani-
Fig. 6.—Photomicrograph of invasive adeno­
carcinoma extending across the field adjacent to 
Thorotrast (arrow) and in its reactive fibrosis 
( hematoxylin-phloxine-saffron stain, original mag­
nification X 86).
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Fig. 8.—Photomicrograph of an autoradiographic 
preparation of tumour tissue showing the charac­
teristic heavy straight lines produced by alpha 
particles from the Thorotrast (dark granular 
clumps). The beaded pattern reflects abundant 
ionization with many silver grains at each point 
(X 500).
mals. In 1937, an editorial in the Journal 
of the American Medical Association7 
warned its readers of the potential hazards 
of the diagnostic use of thorium dioxide, 
saying that it could produce necrosis and 
malignant change in tissues with which it 
remained in contact. In 1938, Romano and 
McFetridge8 described foreign-body reac­
tion to this substance in both humans and 
experimental animals and concluded that 
diagnostically this method did not contri­
bute enough to warrant the risk.
In 1947, MacMahon, Murphy and Bates9 
first reported a sarcoma of the liver in a 
patient who had previously received 
Thorotrast. Since then, over 60 tumours 
thought to be caused by Thorotrast have 
been described. Dahlgren10 reviewed most 
of these in 1961 and, since then, over 30 
more of these tumours have been reported. 
Most of the tumours have been in the liver 
and biliary tract but also in other sites
exposed to the medium, including renal 
pelvis, maxillary sinus, lacrimal duct, ovary 
and breast. Tumours have developed in 
sites distant from that under investigation, 
sites such as the liver, lymph nodes and 
marrow, presumably because the agent was 
transported to these sites where it was col­
lected and stored. Some tissues directly 
exposed, such as meninges, brain, spinal 
cord and related tissues have not devel­
oped tumours, possibly because of local 
resistance or, more likely, because the 
Thorotrast was not retained at these sites.
Breast cancer following the investigation 
of a breast lesion by Thorotrast was first 
described in a man by Austoni11 in 1950. 
Dahlgren10 and Baserga, Yokoo and Hene- 
gar12 quoted this case in their reviews 
of Thorotrast tumours, but Brody and 
Cullen13 did not. Brody and Cullen stated 
that they had found no report of a malig­
nant tumour following the use of Thoro­
trast for mammography and then described 
such a case, but cautiously stated that 
there was no proof of causal relationship.
Intervals between the use of Thorotrast 
and the diagnosis of subsequent tumour
Fig. 9.—Photomicrograph of left axillary node 
showing Thorotrast material (black) within the 
lymph node and also in the adjacent fatty tissue 
(original magnification X 50).
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are reported as 19.4 ±  4.0 years for liver 
carcinoma, 12.6 ±  7.4 years for liver sar­
coma and 14.6 ± 4 . 3  years for extravascu- 
lar sites of injection.12 The intervals in the 
cases mentioned above were 12 and 17 
years, which would fall within the last 
range quoted; the case in this report, 30 
years later, is one of the longest intervals 
reported.
Although surgeons in the 1930s thought 
that Thorotrast was a suitable and easy 
medium to use, the filling of a closed-end 
fine duct system, such as in the breast, 
must have produced problems. The pro­
cedure was safe if the thorium dioxide 
could be completely removed, but if a duct 
ruptured the Thorotrast gained access to 
the connective tissue and remained there, 
producing fibrosis and a potential neo­
plastic change. Patients who have had such 
examinations are now passing from the 
latent period to that of clinical manifesta­
tion and should be closely watched. Many 
such patients may no longer be under 
medical attention; if so, what steps should 
be taken to find and have them periodically 
examined?
Summary
A 60-year-old woman, who had had bi­
lateral mammography with Thorotrast 30 
years before, was found to have an adeno­
carcinoma of one breast in 1969. The other 
breast was subsequently removed and was 
found to contain Thorotrast and fibrosis 
but no tumour.
The potential radiation danger of 
thorium dioxide may be small but, when 
retained at one site over a long period, can 
and has produced carcinomas and sar­
comas of various tissues. Thorotrast was 
popular as a radiologic diagnostic agent 
between 1930 and 1950, then its use de­
clined. Today there is an unknown number 
of people who must have it in their tissues, 
have the potential to develop a malignancy, 
and who should be watched accordingly.
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R e s u m e
En 1969, on a decouvert dans un sein un 
adenocarcinome chez une femme de 60 ans qui 
avait eu une mastographie bilaterale au thorotrast 
30 ans auparavant. On finit par proceder a l’abla- 
tion de l'autre sein qui, a l’histologie, contenait 
du thorotrast et du tissu fibreux mais pas de 
tumeur.
Le danger potentiel de radiation du bioxyde de 
thorium peut etre minime, mais quand cet ele­
ment est retenu en une region donnee pendant 
une longue periode, il peut provoquer des carci- 
nomes et des sarcomes dans divers tissus. Le 
thorotrast a eu la faveur des specialistes comme 
agent de diagnostic radiologique de 1930 a 1950, 
puis sa popularity a decline. II y a aujourd-hui un 
nombre indefini de personnes qui doivent avoir 
du bioxyde de thorium dans leurs tissus, qui 
courent le danger de developper un cancer et qui 
devraient etre surveillees en consequence.
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SUBARACHNOID PHENOL NERVE BLOCKS FOR R E L IE F OF PAIN 
IN ADVANCED MALIGNANCY6
R. J. EVANS, M.R.C.S.[Eng.], C.R.C.S.[C]f and 
I. M. MACKAY, M.D., C.R.C.P.[C],± Toronto, Out.
T his paper describes experience with the 
use of intrathecal injections of phenol in 
glycerin for the relief of intractable pain 
in the lower one-half of the body, associ­
ated with advanced malignancy. Forty- 
nine patients—25 men and 24 women— 
were treated between January 1967 and 
June 1970, and the patients were followed 
at monthly intervals until death,
In 1931, Dogliotti1 first described intra­
thecal alcohol nerve blocks to relieve in­
tractable pain in the lower one-half of the 
body. In the subsequent decade many 
workers reported results of this technique, 
including Stern,2 Saltzstein,3 and Greenhill 
and Schmitz.4 For pain associated with ad­
vanced pelvic malignancies, Greenhill3' K 
later combined intraspinal alcohol injec­
tions with sympathectomy. Maher7 used 
phenol in glycerin (1/18 to 1/20 solution) 
instead of absolute alcohol. Subsequently 
others mixed phenol with iophendylate 
(Pantopaque) in an attempt to inhibit 
selectively pain pathways. In the past de­
cade Nathan,8’ 9 Stewart and Lourie,10 
Mark et al.,n  and Iggo and Walsh12 dis­
cussed this technique and made particular 
reference to its dangers and to histologic 
evidence of the effect of phenol on nerve 
roots. Brown,13 Maher,7 and White and 
Sweet14 have made detailed reports con­
cerning the results of pain management 
using phenol in glycerin.
In 1969, White and Sweet13 summarized 
the consensus at that time by saying: “It 
is still too soon to be sure how well the 
results will stand up, but we are confident 
that it will be possible to avoid major 
surgery in the lower half of the body in 
over half of our future cases. With the
"From the Departments of Surgery and Anes­
thesia, University of Toronto, Toronto General 
Hospital and The Princess Margaret Hospital, To­
ronto, Ont.
t  Director of the Irene Eleanor Smythe Pain 
Clinic; Research Associate, Department of Sur­
gery, University of Toronto.
^Assistant Professor, Department of Anesthesia, 
University of Toronto.
present day use of glycerin as a solvent the 
results have been distinctly better than 
with the earlier solution in Pantopaque, 
and the rate of success is certain to im­
prove with increasing experience.”
Between 1966 and 1970, over 750 pa­
tients with intractable pain were referred 
to the Irene Eleanor Smythe Pain Clinic in 
Toronto. Approximately 75% of these had 
intractable pain associated with advanced 
malignancy. Forty-nine patients (approxi­
mately 10% of cancer patients referred) 
were assessed by a team of doctors, and 
chosen for subarachnoid injection of phenol 
in glycerin. One of us (I.M.M.) did most 
of the nerve blocks on 28 patients (43 of 
73 blocks); those on the remaining 21 were 
done by other specialists in anesthesiology 
or neurosurgery, all of whom had experi­
ence with this technique.
Agents and Procedubes
The intrathecal block procedures were 
all carried out in an operating room under 
strict asepsis, using a solution of phenol in 
glycerin prepared to order by Toronto 
General Hospital pharmacy ( each cubic 
centimetre of the solution contained 0.05 
c.c. of phenol, i.e. 5% phenol in 95% 
glycerin).
The patient is positioned with the pain­
ful side down and the operating table is 
adjusted so that the point of injection, and 
therefore the area to be treated, is at the 
lowest point in the curve of the spinal 
column.
After making a skin wheal with a local 
analgesic, a 20-gauge (or larger) needle 
is inserted into the subarachnoid space. A 
smaller needle is not suitable because of 
the viscosity of the glycerin. When the 
needle has been inserted and a free flow 
of spinal fluid has been established, the 
patient is rotated posteriorly about 30° 
and the phenol-in-glycerin is injected into 
the subarachnoid space over a period of 
five to 10 seconds. Because the solution is 
heavier than cerebrospinal fluid, gravity
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directs it downwards from the point of in­
jection on to the immediately adjacent 
nerve roots.
In this series, we usually injected about 
1 c.c. In a few cases, only 0.75 c.c. was 
injected, and in a small number, when the 
effect of a previous injection had proved 
inadequate, we used 1.3 c.c. to 1.5 c.c.
The patient was kept in the 30° position 
for 30 minutes after injection and then re­
turned to bed and instructed to lie flat— 
not necessarily supine—for 24 hours.
Intrathecal injection of phenol 5% in 
glycerin is followed quickly by a sen­
sation of warmth and sometimes by mild 
paresthesia in the distribution of the roots 
affected. Anesthesia of these roots usually 
follows in a few moments.
In this series, bilateral pain was treated 
by an intrathecal phenol block on the most 
painful side. In some cases we followed 
this by a block on the other side three or 
four days later. Some patients improved so 
much after one injection that the second 
side was not done.
Selection of Patients
Of the 25 men and 24 women in this 
group, 15 were still alive in January 1971. 
Six of the 49 were under 40 years of age, 
18 were between 40 and 59, and 25 were 
more than 60 years old. The sites of 
primary tumour are illustrated in Table I,
TABLE I .— S it e  of P r im a r y  T u m our
Colon and rectum 22
Female genitalia 13
Genitourinary system 2
Others 12
and it will be noted that 37 patients had 
recurrences from primary sites in the colon, 
rectum and female genitalia. All patients 
had localized pain at various sites in the 
lower one-half of the body.
Thirty-two had a single block, 10 had 
two blocks, and seven had three, so that 
49 patients had 73 subarachnoid injections 
of phenol in glycerin. All 49 patients had 
had intractable pain from one to 36 
months, with a mean duration of nine 
morphs. Fifteen had intractable pain from 
one to three months, and the remaining 34 
had pain from three to 36 months. When
they presented at the Pain Clinic, 31 had 
genitourinary symptoms, including diffi­
culty initiating micturition or incontinence 
of urine, or were already on continuous 
catheter drainage. An equal number had 
signs or symptoms in the central nervous 
system, including alteration in sensation to 
pinprick and light touch, deep reflex 
changes, loss of sphincter tone or dimin­
ished muscle power in the lower extremi­
ties. Of the 34 patients who had died from 
their disease at the time of this report, 25 
had lived one to three years from the time 
of their initial diagnosis. Forty-one had 
survived for longer than three months after 
the initial nerve block.
Results
The severity of pain and degree of relief 
were recorded in the patient’s own words, 
and at frequent intervals we related it to 
the analgesic drug requirement and objec­
tive assessment. Table II illustrates the 
duration of the effect of phenol.
TABLE II.— D u ratio n  of Effect of P h e n o l
Less than 1 week 
Less than 1 month 3f| 60%
221 —3 months
3—6 months 3
More than 6 months 1
Unknown 2
Total 73 Blocks
All patients obtained complete relief of 
pain at the time of the block. Thirty-eight 
blocks (50% ) produced relief that lasted 
for less than one week, and seven more 
for one to four weeks, after which the pain 
returned in its former severity, i.e. 45 of 
the nerve blocks relieved pain for less than 
one month. Twenty-two blocks gave relief 
for one to three months, and four blocks 
for more than three months. The follow-up 
on the other two is not known. Eight pa­
tients of the 34 who died from their disease 
had less severe pain up to the time of 
death, but of the eight patients who died 
before three months, five had complete 
relief of symptoms. These results compare 
favourably with those of Gordon and 
Goel,18 and White and Sweet.14 Forty-five 
of these 49 patients needed other anal­
gesics to control their pain after the phenol 
nerve block.
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C om plications
Nine patients (18% ) developed compli­
cations and side effects that we attributed 
to the phenol block. In three, we could not 
withdraw regular morphine medication; in 
two, the injection precipitated urinary in­
continence, requiring continuous catheter 
drainage. One developed foot-drop and 
pain in the foot, and two developed peri­
pheral dysesthesia in the lower extremities, 
with associated weakness in a lower ex­
tremity in one.
Evaluation  of M ultiple Blocks
Thirty-two patients had a single phenol 
nerve block. Two died within one month 
and, of the remaining 30, nine had relief of 
pain for more than one month. Of 10 who 
had a second nerve block, four got relief 
that lasted for more than one month, Of 
those who obtained no benefit from a 
second block, only one got relief for more 
than one month after a third block.
D iscussion
Arbitrarily we have defined “intractable 
pain” as that which has been present for 
more than one month without remission 
in spite of treatment. Intractable pain as­
sociated with advanced malignancy is for­
tunately uncommon,17 but it is a most 
difficult social and medical challenge. The 
assessment of ultimate prognosis following 
initial management of malignancy is no­
toriously difficult and commonly inaccurate. 
Therefore, in making recommendations 
concerning these seriously ill patients, we 
should choose the treatment in the light of 
the ultimate prognosis. With the advent of 
thalamotomy and percutaneous cordotomy 
for the relief of intractable pain, it has be­
come increasingly difficult to select the 
correct treatment for this category of 
patient.
With phenol injections, White and 
Sweet18 treated 30 patients for intractable 
pain associated with colonic, rectal, and 
recurrent cancer of the female genitalia. 
Of these, five had no recurrence of pain to 
death. In our series, eight of 49 were free 
of pain until death.
The procedure described is simple and, 
if necessary, can be performed at the bed­
side. It carries negligible morbidity, but 
the effect is only of short duration, and 
we do not recommend this procedure for 
those who will probably live for longer 
than one month. Those who are expected 
to live longer should be referred for defini­
tive neurosurgical treatment, such as per­
cutaneous cordotomy or thalamotomy.
Although a high percentage of our pa­
tients had neurologic and genitourinary 
symptoms because of advanced disease, 
this did not seem to affect the results of 
the phenol block. We felt these patients 
probably fitted into the category that 
Maher7 described (those with dural in­
filtration and carcinoma coated ganglia), 
and phenol nerve block worked even 
though we didn’t expect it to. We believe 
that if the first attempt produces short­
lived pain relief, a second attempt is 
worth while, but that subsequent phenol 
blocks will probably be ineffective.
Su m m ar y
Forty-nine patients with intractable pain 
associated with advanced malignancy were 
treated by intrathecal injections of 5% 
phenol in glycerin. Only eight patients had 
complete relief of pain until death, and 
90% of these patients needed other anal­
gesics to control their pain. Eighteen per 
cent of patients had some type of compli­
cation or side effect. Patients with intract­
able pain in the lower one-half of the 
body, who are expected to live longer than 
one month, should be referred at once for 
definitive neurosurgical maneuvers, and 
phenol nerve blocks should be reserved for 
those with intractable pain and a very 
short expectation of life. No more than two 
nerve blocks should be attempted, because 
further nerve blocks probably will not pro­
duce relief for longer periods. Phenol 
blocks may also be used as an adjunct to 
unilateral cordotomy when it is unaccept­
able or inadvisable to perform the bilateral 
procedure.
We wish to thank all the physicians who have referred patients with intractable pain to the Irene Eleanor Smythe Pain Clinic for their co­operation in supplying us with details of follow­up, and to the ancillary staffs at The Princess Margaret Hospital, Queen Elizabeth Hospital, and Toronto General Hospital for their invaluable assistance. We would also like to thank Mrs. R. Topp for her secretarial assistance.
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R e s u m e
Nous avons cherehe a soulager la douleur 
opiniatre de 49 malades souffrant d’un cancer 
avance, au moyen d’injections intrathecales d’une 
solution glycerinee a 5% de phenol. Iluit malades 
seulement furent soulages completement jusqu’a 
leur mort et 90% d’entre eux devaient prendre 
d’autres analgesiques pour maitriser la douleur. 
On a note certaines complications ou certains 
effets secondaires chez 18% des malades. Il im- 
porte de soumettre sans delai au neurochirurgien 
le cas des malades dont la douleur rebelle siege 
dans la moitie inferieure du corps et qui ont une 
esperance de vie de plus d’un mois. L ’anesthesie 
tronculaire devra 6tre reservee aux seuls malades 
souffrant de douleur opiniatre et qui n’ont que 
peu de temps a vivre. On ne devra proceder qu’a 
un maximum de deux anesthesies tronculaires, 
car de nouvelles anesthesies risquent de ne pas 
apporter de soulagement pendant des periodes 
plus longues. On pourra egalement utiliser ce 
procede comme adjuvant d’une cordotomie uni- 
laterale, dans les cas ou il est inacceptable ou a 
deconseiller de proceder a la cordotomie bilate- 
rale.
Few antibiotics are so right so often...
for severe Gram-negative hospital infections
Kantrex
KAN AM YCIN S U LFA TE
Kantrex offers a spectrum uniquely suited to hospital 
practice. Few antibiotics provide such broad bactericidal 
coverage against Gram-negative bacteria and hospital 
staphylococci.
The rapid bactericidal action attained with Kantrex permits its use in severe infections be­
fore culture results are known, its rapid absorption and diffusion facilitate penetration to in­
fection sites throughout the body for prompt therapeutic response—usually in 24-48 hours— 
and remission usually within 5-7 days.
Prompt use of Kantrex in Klebsiella pneumonia may save a lung or a life. Prompt use In 
pyelonephritis may reduce renal destruction so often seen in Proteus infections. Prompt 
use in bacteremia may prevent impending shock and fatality.
New dosage guidelines assure low risk of toxicity. A simple basic dose of 7.5 mg./ Kg./
I.M. applies to all patients on Kantrex therapy. In patients with normal renal func­
tion, Kantrex injections are given twice a day; when renal impairment is present, 
the dose remains the same'but the time interval between doses is increased 
depending upon the serum creatinine concentrations of the patient.
To calculate the time interval between the first and succeeding doses . Hg 
of Kantrex in patients with decreased renal function, simply multiply 
the mg. of creatininex 9—e.g. if serum creatinine levels are 2 mg./
100 ml., the dosage interval should be 2 x 9 =  18 hours be­
tween Kantrex doses.
In anuric adults give 7.5 mg./Kg./I.M. as a single loading 
dose. In adults on hemodialysis, 7.5 mg./ Kg./ I.M. every other 
dialysis.
To avoid ototoxicity, daily Kantrex dosage should not ex­
ceed 1.5 Gm. and total therapy should not exceed 15 Gm. or
10 days.
When dosage recommendations are followed, therapeutic 
levels of Kantrex are maintained with low risk of toxicity.
Current evaluations of the Kantrex-neomycin-gentamicin 
group of antibiotics cite Kantrex as the safest for parenteral 
administration.1-2
Kantrex
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Injection
PRESCRIBING INFORMATION. For complete 
information, consult Package Circular.
Indications: Infections of the urinary, respira­
tory and gastrointestinal tracts and of skin, soft 
tissues, bone periosteum and blood due to sen­
sitive organisms.
Contraindications: A history of hypersensitivity 
to the drug. Prior auditory damage by kana- 
mycin or other agents may be a contraindica­
tion if effective alternative therapy is available.
Warnings: Renal malfunction can cause ab­
normally high serum levels of kanamycin— as­
sess renal function periodically both before and 
during therapy. If renal insufficiency exists, de­
crease the size and frequency of dosages. Dis­
continue kanamycin and check hearing if 
azotemia increases. In older patients and pa­
tients receiving a total dose in excess of 15 
Grams, watch carefully for signs of ototoxicity.
Precautions: If mycotic or bacterial superinfec­
tion occurs, discontinue kanamycin and initiate 
appropriate therapy. Cumulative ototoxic effects 
may be produced by concurrent or consecutive 
use of other ototoxic drugs. High doses may 
cause irritation at infection sites. Th e  drug 
should not be physically mixed with other anti­
microbials.
Adverse Reactions: Severe, irreversible hearing 
loss can occur. Stop therapy if tinnitus or hear­
ing loss occur. Signs of renal irritation may 
occur (casts, cells, proteinuria). If renal func­
tion is normal such irritation is reversible and 
is not necessarily an indication for stopping 
therapy. Skin eruptions have been noted rarely. 
To avoid respiratory depression, postpone intra- 
peritoneal instillation in postoperative patients 
until recovery from anesthesia and muscle re- 
laxants is complete.
Usual Dosage: 15 mg./Kg./day I.M. in divided 
doses preferably at 12-hour intervals. Average 
adult dose is 1 Gram daily. Do not exceed 1.5 
Gram even in the heaviest patients. Reduce size 
and frequency of dosages when renal insuffi­
ciency is present. Patients should be well hy­
drated to minimize renal irritation. Inject deeply 
into the upper wall, outer quadrant of the glu­
teal muscle.
Supplied: Rubber capped vials as a ready-to-use 
sterile aqueous solution in two concentrations: 
0.5 Gm. in 2 ml. 1.0 Gm. in 3 ml. Also Available 
— Pediatric Injection 75 mg. in 2 ml.
Complete prescribing information available 
on request.
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BOOK REVIEW ERS, 1971
The physicians, other medical scientists and members of allied health professions, 
who month by month assist the Editor of The Canadian Journal o f Surgery by con­
tributing book reviews, make a significant contribution to continuing medical educa­
tion. The Editorial Board and the Editor wish, at this time, to acknowledge with 
gratitude the assistance, during 1971, of their colleagues whose names appear below.
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THE CANADIAN JOURNAL OF SURGERY
All communications concerning this journal 
should be marked “The Canadian Journal of 
Surgery” and addressed to the Editor, 530 
Scarlett Road, Suite 1002, Weston 626, Ont.
The Journal is published bi-monthly. Sub­
scription is $15 per year ($7.50 per year for 
trainees in surgery), and starts with the Janu­
ary issue of each year. Single copies are $2.50 
each, payable in advance. (It would be greatly 
appreciated if subscribers would add bank ex­
change to their cheques.)
INSTRUCTIONS TO CONTRIBUTORS 
Manuscripts
Manuscripts in duplicate of original articles, 
case reports, and other contributions should 
be forwarded with a covering letter re­
questing consideration for publication in The 
Canadian Journal of Surgery. Acceptance 
is subject to the understanding that they 
are submitted solely to this Journal, and 
will not be reprinted without the consent 
of the author and the publishers. Accept­
ance or rejection of contributions will be 
determined by the Editorial Board. As 
space is available, a limited number of 
case reports will be published. Articles 
should be typed on one side only of un­
ruled paper, double-spaced, and with wide 
margins. The author should always retain a 
carbon copy of material submitted. Every 
article should contain a summary of the 
contents. The Concise Oxford Dictionary 
will be followed for spelling. Borland’s 
Illustrated Medical Dictionary will be fol­
lowed for scientific terminology. The Edi­
torial Board reserves the right to make the 
usual editorial changes in manuscripts, in­
cluding such changes as are necessary to en­
sure correctness of grammar and spelling, 
clarification of obscurities or conformity 
with the style of The Canadian Journal of 
Surgery. In no case will major changes be 
made without prior consultation with the 
author. Authors will receive galley proofs 
of articles before publication, and are asked 
to confine alterations of such proofs to a 
minimum.
Reprints
Reprints may be ordered on a form which 
will be supplied with galley proofs. It is 
important to order these before publication 
of the article, otherwise an extra charge 
for additional type-setting will be made.
References
References should be referred to by numer­
als in the text. They should include in 
order: the author’s name and initials in capi­
tals, title of the article, abbreviated journal 
name, volume number, page number and 
year. The abbreviations of journal names 
should be those used in Index Medicus. 
References to books should include in order: 
author’s name and initials, title of book, 
number of edition (e.g. second ed.), city 
of publication, title of publishing house, 
year of publication, page number if a 
specific reference. For examples, see this 
journal January 1971 issue onwards.
Illustrations
A reasonable number of black-and-white 
illustrations will be reproduced free with 
the articles. Colour work can be published 
only at the author’s expense. Photographs 
should be glossy prints, unmounted and 
untrimmed, preferably not larger than 8" 
x 6". Prints of radiographs are required 
and not the originals. The magnification of 
photomicrographs must always be given. 
Photographs must not be written on or 
typed on. An identifying legend may be 
attached to the back. Patients must not be 
recognizable in illustrations, unless the 
written consent of the subject for publica­
tion has been obtained. Graphs and dia­
grams should be drawn in India ink on 
suitable white paper. Lettering should be 
sufficiently large that after reduction to 
fit the size of the Journal page it can still 
be read. Legends to all illustrations should 
be typed separately from the text and sub­
mitted on a separate sheet of paper. Illustra­
tions should not be rolled or folded.
Language
It should be clearly understood that con­
tributors are at full liberty to submit 
articles in either English or French, as they 
please. Acceptance will be quite independ­
ent of the language of submission. If the 
contributor wishes, he may submit an in­
formative summary of not more than 300 
words in the language other than that in 
which he has submitted the article. For 
example, an article in English must carry 
an English summary and may, if the author 
wishes, carry a more detailed summary in 
French.
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LE JOURNAL CANADIEN DE CHIRURGIE
Toute communication concernant le Journal 
devra porter la mention “Le journal canadien de 
chirurgie” et etre adressee a l’Editeur, 530 
Scarlett Road, Suite 1002, Weston 626, Ont.
Le journal est publie a tous les deux mois. Le 
prix de l’abonnement est de $15. par an ($7.50 
par an pour les medecins qui sont residents en 
chirurgie) et commence avec le numero de 
janvier de chaque annee. Un exemplaire isole 
coute $2.50 et est payable d’avance. (Nous 
serions reconnaissants aux souscripteurs de vou- 
loir bien ajouter a leur cheque le montant des 
frais bancaires eventuels).
INSTRUCTIONS A NOS
COLLABORATEURS
Manuscrits
Les manuscrits d’articles originaux, de rap­
ports cliniques etc. seront envoyes en deux 
exemplaires, accompagnes d’une lettre deman­
dant qu’on veuille bien considerer leur publica­
tion dans L e journal canadien de chirurgie. Ils 
ne seront aeceptes qu’a la condition qu’ils 
n’aient ete soumis qu’a notre Journal et qu’ils 
ne soient pas reimprimes sans le consentement 
expres de l’editeur et l’auteur. L ’acceptation 
ou le refus des articles soumis releve du Con- 
seil de la publication. Si la place est disponible, 
un nombre limite d’histoires cliniques pourront 
etre publies. Les articles seront dactylographies 
sur un seul cote d’un papier non ligne, a double 
espace et avec une large marge. L’auteur devra 
toujours conserver une copie au papier carbone 
du texte soumis. Tout article devra etre ac- 
compagne d’un resume. L ’orthographe sera 
celle adoptee par le dictionnaire Larousse. 
Quant a la terminologie scientifique, elle sera 
basee sur le Dictionnaire des termes techniques 
de medecine ou tout autre ouvrage de refe­
rence serieux. Le Conseil de la publication se 
reserve le droit d’apporter au texte les change- 
ments qu’il jugerait a propos pour assurer la 
correction grammaticale et l’orthographe, pour 
eliminer d’eventuelles obscurites ou pour ren- 
dre la presentation conforme au style du Jour­
nal canadien d e chirurgie. Aucun changement 
important ne sera apporte au texte sans que 
l’auteur ait ete prealablement consulte. Les 
auteurs recevront avant la publication des 
epreuves d’imprimerie de leur texte, auxquelles 
ils sont pries d’apporter le minimum de correc­
tions.
Tires-a-part
On pourra commander des tires-a-part sur 
une formule qui est envoyee avec les epreuves. 
II est important de les commander avant la 
publication de l’article, sous peine de devoir 
payer un supplement pour une nouvelle com­
position.
Bibliographic
Les references bibliographiques seront indi- 
quees par des numeros dans le corps du texte. 
Elies comprendront dans l’ordre: le nom de 
l’auteur et ses initiales, en majuscules, le title 
abrege du Journal, le numero du volume, le 
numero de la page et l’annee. Les abreviations 
admises pour les noms de revues sont celles qui 
figurent dans I’Index Medicus. Les renvois aux 
livres comprendront dans l’ordre: le nom de 
Tauteur, ses initiales, le titre de l’ouvrage, le 
numero de l’edition (p. ex. deuxieme ed.), la 
ville et le nom de la maison d’edition, et 
l’annee de la publication; enfin, le numero de 
la page s’il s’agit d’un renvoi precis. Pour 
examples, voyez Tissue de janvier 1971 et ceux 
a venir.
Illustrations
Le journal accepte de publier gratuitement 
un nombre raisonnable d’illustrations en noir 
et blanc. Les reproductions de cliches en cou- 
leurs seront publiees aux frais de Tauteur. Les 
photographies seront imprimees sur papier bril- 
lant, ne seront ni montees ni calibrees et d’un 
format maximum de 6" x 8". En ce qui con- 
cerne les radiographies, nous demandons des 
copies et non pas Yoriginal. On devra toujours 
foumir un agrandissement de microphoto­
graphies. Il ne faut jamais ecrire ou dactylo- 
graphier un texte quelconque sur les photo­
graphies. Une legende les identifiant pourra 
etre jointe au dos. Dans les illustrations mont- 
rant des malades, ceux-ci ne pourront etre 
reconnus, a moins qu’ils n’en aient donne le 
consentement ecrit prealablement a la publica­
tion. Les graphiques et diagrammes seront des- 
sines a l’encre de Chine sur un bon papier a 
dessin blanc. Le lettrage devra etre ecrit en 
caracteres assez grands pour que, apre reduc­
tion proportionnelle au format du Journal, ils 
soient encore lisibles. Les legendes devant 
accompagner les illustrations seront dactylo­
graphies sur une feuille independante du 
texte. Les illustrations ne seront ni roulees ni 
pliees.
Langue vehiculaire
II doit etre clairement etabli que les colla- 
borateurs ont pleine liberte de soumettre leurs 
articles en francais ou en anglais, a leur choix. 
L ’acceptation de Tarticle sera entierement inde­
pendante de la langue choisie par Tauteur. Si 
le collaborateur le desire, il peut decrire le 
contenu de Tarticle en un sommaire ne depas- 
sant pas 300 mots et dans une langue differente 
de la langue choisie pour Tarticle lui-meme. 
Par exemple, un article ecrit en frangais doit 
comporter un resume en frangais et peut, si 
Tauteur le desire, etre accompagne d’un som­
maire plus detaille en anglais.
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B OOK R E V I E W S
ASPIRIN, PLATELETS AND STROKE. Back­
ground for a Clinical Trial. Compiled and 
edited by William S. Fields and William K. 
Hass. 153 pp. Illust. Warren H. Green, Inc., 
St. Louis, 1971. $10.50.
This little book contains the verbatim report 
of a meeting held in Houston, Texas, to dis­
cuss the feasibility of a co-operative study or 
a controlled clinical trial of aspirin, in an at­
tempt to determine whether or not it could 
be used to modify platelet emboli. If so, the 
management of transient ischemic attacks 
might be altered.
The book is an excellent description of the 
current status of radiologic interpretation of 
atherosclerotic lesions in the vessels of the 
head and neck. There is an extensive descrip­
tion of the actions of platelets and the role of 
aspirin on platelet function. One section deals 
with the effects of aspirin as a specific drug 
in actions other than those on platelets and 
reflects the current knowledge of aspirin 
metabolism. The final section describing the 
problems of controlled clinical trials is well 
worth reading.
With the current interest in platelet 
metabolism and the actions of blood and 
blood constituents on the vessel wall, this book 
is timely and appropriate. It is easy to read 
and will serve as a reference for workers not 
specifically involved in this field. Anyone 
interested in the problems of thromboembol­
ism, whether arterial or venous, will find this 
book profitable. It has immense clinical 
significance for everyone in surgery and its 
specialties.
CHEST INJURIES. Physiologic Principles and 
Emergency Management. Emil A. Naclerio. 383 
pp. Illust. Grune & Stratton, Inc., New York, 
1971. $28.50.
It was a pleasure for the reviewer to read 
this book, which was also given to his resident 
to review; he, too, heartily endorsed it as a 
valuable text in the diagnosis and treatment 
of acute chest injuries. As the author states, 
this is not an exhaustive treatise but it out­
lines, with commendable brevity and clarity, 
the management of every conceivable cause of 
chest trauma that can occur in civilian prac­
tice. The book to some extent is dogmatic 
hut this dogmatism is refreshing because it 
comes from an individual who has un­
paralleled experience with peace-time injuries 
to the thoracic cage and intrathoracic struc­
tures. The references are up to date and rele­
vant and are not inserted throughout the text 
to distract the reader.
Dr. Naclerio has emphasized the fact that 
the management of such patients is a team 
effort involving multiple disciplines and all 
surgical specialties as well as paramedical
personnel. This book can be recommended to 
everyone associated with the management of 
the acute chest injury, whether as a con­
sultant, a resident or a medical student. It 
should not only be available in every library 
and emergency department but should be 
compulsory reading for those involved in the 
management of patients with chest trauma.
CONGENITAL ABSENCE OF THE EAR. Eric 
W. Peet. 39 pp. Illust. E. & S. Livingstone 
Ltd., Edinburgh; Longman Canada Limited, 
Toronto, 1971. $7.25.
Mr. Eric Peet, the former Director of the 
Department of Plastic Surgery, Churchill Hos­
pital, Oxford, has demonstrated a lifetime 
interest in congenital absence of the ear. Un­
fortunately, this text is a posthumous credit 
to his sincere depth of understanding of both 
the patient’s regional deficiencies and the 
surgeon’s frustrations.
This text contains his personal experience 
after many years’ attempt to improve the re­
sults of total ear reconstruction. There is a 
natural progression throughout the text as the 
author demonstrates his own imaginative con­
cepts coupled with the published experiences 
of others.
He divides his text into four distinct 
chapters; general considerations, general 
principles, details of reconstruction of the 
pinna and construction of a sound conduc­
tor and the external auditory canal.
Mr. Peet outlines most of the shortcomings 
and problems encountered in this type of 
surgery. In the appendix he has presented a 
pictorial record of six patients with microtia 
and has demonstrated the end results.
Although this is a specialized subject and 
of only limited appeal, it should, hopefully, 
find a permanent place in the library of most 
reconstructive surgeons. The author’s thought­
ful dedication is evidenced throughout the 
text and further reinforced by the efforts of 
his associates Messrs. Patterson and Batstone. 
This is an inexpensive yet worthwhile mono­
graph.
FETTSTOFFW ECHSELSTORUNGEN. IHRE 
ERKENNUNG UND BEHANDLUNG. Edited 
by Gotthard Schettler. 184 pp. Illust. Inter­
continental Medical Book Corp., New York; 
Georg Thieme Verlag, Stuttgart, 1971. DM 
24,00. $7.00 (approx.). Paperbound.
Problems related to fat metabolism are dis­
cussed frequently in the professional journals 
and also in the lay press. The publication of a 
monograph devoted to these problems, there­
fore, is timely. In the first chapter, the 
clinical picture of the five types of hyperlipo-
(Continued on Adv. page 20)
The
Second Step 
in Treating 
Shock
vasoden'tine, n. ( vaso-. and L. tints. Jm tis .  a tooth.) in an­
atomy, a modification of dentine in which capillary tubes 
o f the primitive vascular pulp remain uncalcified and carry 
red blood into the substance o f the tissue.
vas"6-di-la, tion. n. expansion o f a vessel: particularly of W  
arterioles resulting in increased blood flow. |
v»s"d-di*lit,or, a. producing dilatation of the blood vessels.
vas"o-dMsit'or, n. a vasodilator nerve or drug.
vasoform 'ahve. a. in physiology, building up new blood y . 
vessels or vascular tissue.- - - . yvas-o-hy-per-ton'ic, a. same as vasoconstrictor.
vas-d-by-po-ton'tc, a. same as vasodilator.
vas"oin*hib'itor, n. any agent or drug that inhibits the action 
o f the vasomotor nerves.
vas',oinhtb/i t d n ,  a. hindering the action of the vasomotor
nerves. i
vas-o-mS'tton, n. in anatomy, the contraction or dilatation of......
the caliber o f a blood vessel. ; |
vas-o-mo'tor, a. (raso- and m otor.) in physiology, regulating ~ J 
the size <i.e.. caliber) of blood vessels by causing contraction
Volume replacement -  accompanied by appropri­
ate antibiotic therapy when necessary -  is the es­
sential first step in shock therapy.
However, when volume replacement alone fails to 
reduce peripheral resistance, improve tissue per­
fusion and restore cardiac output, additional drug 
therapy is required.
vasodilation-
the important second step
Authorities report that a growing trend in the 
treatment of severe shock is the use of vasodila­
tors to restore haemodynamic balance.
One author1 suggests that there are three general 
types of drugs that induce vasodilation:
•  those, such as isoproterenol, which produce di­
rect vasodilation:
• those, such as phentolamine, which produce 
vasodilation by blocking the vasoconstrictive ef­
fects of epinephrine, norephinephrine, and related 
substances;
•  those, such as Solu-Medrol, which produce 
vasodilation by unknown means.
Each of these drugs works to reduce vascular re- 4 
sistance and thus lessen the workload on the 
heart. The difference among them is in the quality  ^
of vasoactive response which each induces. 
Isoproterenol -  an effective cardiotonic agent as i 
well as a peripheral vasodilator -  produces its 
greatest amount of vasodilation in the skeletal 
muscle beds which are adequately perfused in 
most shock patients. Vasodilation is only minimal 
in the viscerocutaneous beds where the need for ,, 
blood is greatest.
When isoproterenol is given alone in sufficient r 
amounts to increase cardiac output and reduce 
peripheral resistance, tachycardia, arrhythmia, or 1 
tachyphylaxis may occur. ^
Phentolamine is one of several drugs which pro­
duce vasodilation by blocking the effects of the v  
endogenous catecholamines and thereby reduc­
ing vasoconstriction produced by increased sym- V 
pathetic tone.
The drug takes effect within 5 to 15 minutes and is * 
short-acting. Because of this, it must be given as t  
a continuous infusion requiring constant and care­
ful monitoring. Its effects are extremely difficult to * 
regulate by the intravenous drip technique.
Dosage and Administration: In severe shock, ad junctive use of 
So lu-M edro l may aid in achieving haemodynamic restoration. 
C ortico id  therapy should not replace standard methods of 
com bating shock, but present evidence indicates that concur­
rent use of large doses of cortico ids w ith other measures may 
im p ro ve  su rv iva l rates. In p a rticu la r, la rge  p h a rm a co lo g ic  
doses of Solu-M edrol have been proved useful in bacteraamic 
o r endotoxin  shock, haemorrhagic shock, traum atic shock, and
cardiogenic shock. The fo llow ing  Solu-Medrol doses are sug­
gested by various authors:
Author
Oaks2
W eil3
M elby'
Cavanagh5
Dietzman4
Dose 
100 mg 
200 mg 
250 mg 
15 m g/kg  
30 m g/kg
Repeat
every 2 to 6 hours 
100 mg every 4 to 6 hours 
every 4 to 6 hours 
every 24 hours 
in 4 hours if needed
Therapy is in itia ted by adm inistering Solu-Medrol intravenously 
over a period o f one to several minutes. In general, therapy 
should be continued on ly un til the patient's condition has sta­
bilized -  usually not beyond 48 to 72 hours.
r
r
*¥
t
R»
.
Solu-Medrol
a different type of vasodilator
Solu-Medrol, a corticosteroid, produces vasodila­
tion whengiven in massive(pharmacologic)doses. 
, Although its exact mode of action is not known, it 
is thought that the drug has at least two effects:1
’ • it slows transmission of sympathetic nerve im­
pulses thus delaying the release of the endoge­
nous catecholamines
'  • it preserves the integrity of the capillaries in the
face of anoxia
yr
These and other effects produce measurable de- 
"r  creases in the resistance of the viscerocutaneous
microcirculation.
T
The amount of vasodilation produced by Solu- 
V' Medrol is dependent on the dose. The steroid 
should be administered as a single intravenous 
v bolus over a 3 -to 5-minute period.
^ Because it produces a gradual response, Solu- 
Medrol is easily monitored by the attending phy- 
'  sician. It can be administered quickly and easily 
T in a single intravenous bolus thus eliminating the 
need for the intravenous drip technique. Adverse 
r effects associated with short-term pharmacologic 
doses of Solu-Medrol are uncommon.
Clinical confirmation of corticosteroid 
effectiveness and safety in shock
“The corticosteroids are effective in most patients 
and are, we believe, the best vasodilators availa­
ble to the practicing physician.”
Dietzman, R.H., et al. (1970). Pharm. for Phys., 4(8):1.
“ ...we believe that until physicians develop awider 
experience with rapid-acting adrenergic blocking 
agents, it is safer to use hydrocortisone [cortico­
steroid] as the initial treatment of apparent irre­
versible shock in patients.”
Lillehei, R.C.,et al. (1964). Ann. Surg., f60(4):682.
Solu-M edrol may be given by intravenous in jection, by in tra ­
venous infusion, or by intram uscular in jection. The preferred 
method fo r in itia l em ergency use is intravenous in jection.
Supplied: Mix-O-Vials con ta in ing  40 mg, 125 mg, 500 mg, and 
the new 1 Gm vial w ith w ater fo r in je c tio n , m ethylpredniso- 
lone as m ethylprednisolone sod ium  succina te .
■4 Cautions: The general precautions and contra ind ications to  
sys tem ic  c o r tic o s te ro id  the rapy  a p p ly  to the  use of S o lu - 
-( Medrol. However, when used for medical emergencies or in 
s h o c k - lik e  sta tes, the  po ss ib le  lifesav in g  e ffe c ts  m ust be 
, weighed against the possib le undesired hormonal effects. 
t In the treatment o f shock, Solu-M edrol should be ad junctive 
to  conventional supportive therapy such as flu id  replacem ent, 
etc. A lthough adverse effects associated with high-dose short­
term cortico id  therapy are uncommon, peptic ulceration may 
occur.
References: 1. Dietzman, R.H., et al. (1970). Pharm. for Phys.,4(8):1. 
2. Oaks, W.W., et al. (1967). Geriatrics, 22:120. 3. Weil, M. H., et al. 
(1964). Ann. Int. Med., 60:384 . 4. Melby, J.C. (1964). New Phy„ (3:426.
5. Cavanagh, D., et al. (1968). Amer. J. Obstet. & Gynec., 702:13.
6. Dietzman, R.H.,et al. (1967). GP, 36:135.
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proteinemia is described briefly. The physico­
chemical characteristics of the different types 
of plasma lipoproteins are described in some 
detail. The main part of the monograph is 
devoted to a description and a discussion of 
the dietary treatment of various hyperlipoid- 
emias, the importance of the cholesterol levels, 
the relationship between nutrition and 
coronary infarction and the prevention of 
coronary disease by dietary means. The last 
chapter is devoted to a brief description of 
the role of essential fatty acids and of pro­
staglandins. Some of the material presented is 
rather controversial. The reader may not 
agree with some of the authors’ conclusions, 
but, nevertheless, they present an interesting 
review of present opinions. Dietary measures 
aimed at decreasing the levels of cholesterol 
and of lipids are emphasized whereas the 
relationship between sugar consumption and 
atherosclerosis is rejected.
THE HAND. Lee Milford (from the 5th edition 
of Campbell’s Operative Orthopaedics, edited 
by A. H. Crenshaw). 282 pp. Must. The C. V. 
Mosby Company, St. Louis, 1971. $20.50.
This book is a reproduction of Chapter IV 
of the fifth edition of Campbell’s Operative 
Orthopaedics . In 259 pages, of which almost 
one-half consist of illustrations, the author has 
attempted to cover all facets of hand surgery. 
Starting with basic plastic surgery techniques 
and passing through hand injuries, amputa­
tions, reconstruction, rheumatoid and cerebral 
palsied hand, he completes the book with 
sections on congenital anomalies, tumours of 
the hand and pyogenic infections.
Most of the book is a detailed discussion of 
operative technique with little discussion 
of pathophysiology and almost no comparison 
of the results of these techniques. The entire 
book is basically a reproduction of the best 
artic’es on each aspect of hand surgery. The 
illustrations are nearly all exact reproductions 
from these articles. For instance, the best 
classic drawings of J. W. Littler are included. 
The illustrations from an article by W. L. 
White on tendon transfers, which appeared in 
the Surgical Clinics o f North America in 1960 
are reprinted in their entirety.
There is considerable imbalance which can­
not be explained solely by trying to cover too 
much in too few pages. For instance, two 
pages are devoted to the Allen test for vascu­
lar insufficiency, while no mention is made of 
malignant skin tumours in the section on 
tumours of the hand. Similarly, on the rheu­
matoid hand, three pages are devoted to the 
Fowler and Vainio arthroplasties for the meta­
carpal joints, while joint prostheses are dis­
missed in one sentence. It also appears as 
though the author has little experience with 
several of the techniques mentioned, such as
y
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the Howard technique for the management of 
flexor and extensor tendon adhesions.
This book, which will be useful mainly to 
the student commencing a study of hand sur­
gery, provides an extensive bibliography of the 
better articles on this subject. It will prove of 
little use to the advanced student or experi­
enced hand surgeon looking for new tech­
niques or comparisons of the results of known 
methods.
HEPATIC FAILURE. Henry Brown. 137 pp. 
Illust. Charles C Thomas, Publisher, Springfield, 
111.; McGraw-Hill Company of Canada, To­
ronto, 1970. $10.50.
This excellent little book presents an up-to- 
date summary of present knowledge of the 
anatomy and physiology of the liver together 
with the pathophysiology of hepatic failure. 
From these considerations are derived the 
rationale for therapy.
The book is clearly written. Line drawings 
explain points well and the list of references 
for each chapter is exhaustive enough to 
allow the reader to delve deeper into the 
subject if he so wishes.
The book is an admirable summary of 
present knowledge and will he particularly 
suitable for final-year medical students and 
residents wishing to learn about the subject, 
and for experienced practitioners who wish 
to review and update their understanding of 
the whole field of hepatic function. The book 
is short enough to be read through without 
an excessive use of time, yet complete 
enough to _ -ovide a good general understand­
ing.
KURZE HNO-OPERATIONSLEHRE FUR 
ARZTE UND STUDIERENDE. Band 1: Op­
erative Eingriffe an Nase, Nasen- und Mund- 
rachen, Hypopharynx, Kehlkopf und ausserem 
Hals. Gerhard Theissing. 308 pp. Illust. Inter­
continental Medical Book Corp., New York: 
Georg Thieme Verlag, Stuttgart, 1971. DM 
49,00. $14.30 (approx.). Paperbound.
As the title indicates, the book was written 
for those who are starting the study of sur­
gery, covering the areas noted in the title. 
In a short span this book gives maximum 
information about basic principles of surgery 
in general, about the methods of surgery for 
various areas of the face, head and neck. 
The individual chanters of the book cover 
main surgical procedures for treatment of in­
flammatory processes in these regions, the 
surgery of tumours, congenital anomalies, in­
juries and post-traumatic deformities.
The description of operational methods is 
thorough, with steps of the surgery presented 
in chronological order, the most popular opera­
tions being demonstrated with schematic draw­
ings. The details of the operative treatment 
using different surgical procedures is very 
good for those intending to work in surgery.
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This book is a valuable aid to physicians 
and students who require a generalized 
picture of surgical problems of the head, 
face and neck, where the interests of a few 
surgical specialists meet.
LUNGENMYKOSEN. Vortrage der Friihjahrstag- 
ung der Rheinisch-Westfalischen Vereinigung 
fur Tuberkulose- und Lungenheilkunde am 14. 
Marz 1970 in Diisseldorf. Edited by Hans 
Bartseh. 64 pp. Illust. Intercontinental Medical 
Book Corp., New York; Georg Thieme Verlag, 
Stuttgart, 1971. DM 22,00. $6.40 (approx.). 
Paperbound.
Papers presented at a meeting on fungus in­
fection of lungs held in West Germany in 
1970 are presented in this short monograph. 
Emphasis is placed on the infections occurring 
in Europe. The infections occurring in other 
parts of the world, including histoplasmosis, 
coccidioidomycosis, blastomycosis and sporo­
trichosis, are mentioned but treated very 
briefly. For this reason, the book is of limited 
interest to practitioners in this country.
A PRACTICE OF THORACIC SURGERY. 3rd 
ed. A. L. d’Abreu, J. Leigh Collis and D. B. 
Clarke. 652 pp. Illust. Edward Arnold (Pub­
lishers) Ltd., London; The Macmillan Company 
of Canada Limited, Toronto, 1971. $49.50.
The third edition of this book does not live 
up to the high quality of its predecessors. The 
complexity of thoracic surgery led Dr. 
d’Abreu to enlist the help of Drs. Collis and 
Clarke to expand this volume. Drs. Collis and 
Clarke have added substantially to the value 
of this edition but they have attempted to 
cover too much, and many areas have re­
ceived rather cursory treatment. It would, 
perhaps, be better to leave out an entity than 
to mention it just for the sake of completeness.
The section on pacemakers is inadequate. 
The sections on cardiac surgery, although 
helpful in many areas, gloss over many prob­
lems, e.g. in the area of valve replacement, 
to such an extent that it is too sketchy for 
the specialist. This reviewer would argue with 
the authors’ selection of atrial-femoral bypass 
for thoracic aortic aneurysms. Femorofemoral 
bypass is much safer and simpler. Also the 
approach to an aorticopulmonary window 
through the pulmonary artery is much less 
preferable than the transaortic approach. In 
short, the section on the surgery of the heart 
and great vessels is a distinct disappointment.
The strength of this book lies in the sec­
tions on the lung, the esophagus and the 
diaphragm. These areas are masterfully 
covered by experts whose experiences are 
almost without parallel.
Tandearil
oxyphenbutazone pu|| information is available
on request
G-2325-71
Geigy Pharmaceuticals
Montreal 308, P.Q.
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Although this text remains an important 
contribution in its field primarily because it 
reports the experience from one major 
thoracic centre, it cannot be recommended 
for the specialist thoracic surgeon. It would 
be of more value to a general thoracic surgeon 
or to the general surgeon who requires a 
lucid text to which to turn for advice. The 
bibliography at the end of each chapter could 
be updated, because it is not comprehensive 
(perhaps it was not intended to be) and in 
many areas the most recent references are 
two to three years old. The illustrations and 
the quality of publication are excellent but 
the price ($50.00) will deter the average 
practitioner.
NEPHRON FAILURE. Conservation. Substitu­
tion. Replacement. John B. Dossetor and M. 
Henry Gault. 303 pp. Illust. Charles C Thomas, 
Publisher, Springfield, 111.; McGraw-Hill Com­
pany of Canada, Toronto, 1971. $23.75.
This excellent text covers the complete 
spectrum of renal failure and its diagnosis and 
treatment. Physiologic principles are used as 
the basis for treatment and one is impressed 
with reference to the large personal experi­
ence of the authors throughout this mono­
graph. Emphasis is placed on the require­
ment for knowledge of the entire spectrum 
of renal failure so that management at one 
stage does not compromise treatment at a 
later time in the disease.
The practical aspects of management are 
presented in a most readable and helpful 
form; for example, the supplier of bread made 
from glutin-free flour, important in manage­
ment of some patients in the first stage of 
renal failure, is listed. The authors, although 
actively involved in renal transplantation, re­
main objective and emphasize the comple­
mentary functions of dialysis and transplanta­
tion in the treatment of end-stage renal dis­
ease.
The text considers the effect of nephron 
failure on other organ systems, on drug dos­
age, on carbohydrate, fat and protein metabol­
ism, all of which make up 13 of the 22 
chapters.
All physicians and surgeons who must 
evaluate and treat patients with renal failure 
will find this a most useful and mature sum­
mary of current thought and practice.
PATHOLOGISCHE ANATOMIE. Vol. I. AHge- 
meine Pathologie. 3rd ed. Hans Ulrich Zollin­
ger. 336 pp. Illust. Intercontinental Medical 
Book Corp., New York; Georg Thieme Verlag, 
Stuttgart, 1971. DM 12,80. $3.75 (approx.). 
Paperbound.
This small book, which first appeared in 1968, 
is already available as a revised third edition. 
In the meantime it has been translated into 
French, thus it appears to be very popular.
In the first volume, the author, who is Pro­
fessor of Pathology at the University of Basle, 
has reviewed the various aspects of general 
pathology in a rather didactic manner with­
out getting involved with some of the more 
controversial topics. The areas covered in­
clude: malformations, regressive changes, pro­
gressive changes, general pathology of respira­
tion and circulation, inflammation, tumours 
and disturbances caused by chemical and 
physical means such as heat, electricity, and 
irradiation. The book is well organized but 
somewhat difficult to read because it is written 
in a telegraphic style and uses abbreviations 
rather extensively. The book is directed pri­
marily to medical students, but can also be 
recommended to graduates preparing for 
specialty exams, if they have a reasonable 
reading knowledge of German.
MENISCUS LESIONS. Practical Problems of 
Clinical Diagnosis, Arthrography and Therapy. 
P. Ricklin, A. Riittimann and M. S. del Buono. 
American translation by Karl H. Mueller. 142 
pp. Illust. Intercontinental Medical Book Corp., 
New York; Georg Thieme Verlag, Stuttgart, 
1971. DM 59,00. $16.35 (approx.).
Although the title suggests that this is a text­
book on meniscus injuries, it is really a mono­
graph on arthrography of the knee. Eighty- 
six of the 132 pages are devoted to this sub­
ject.
The remaining sections dealing with 
anatomy, pathogenesis, diagnosis and treat­
ment are brief and not as complete as those 
presented in many standard texts on the sub­
ject. This reviewer would disagree with 
certain statements on the function of menisci. 
Some aspects of proposed treatment are also 
controversial. The authors, for example, ad­
vocate the removal of menisci in tibial plateau 
fractures—a practice that most surgeons would 
oppose.
The section on arthrography is excellent. A 
double contrast, air and a water-soluble 
iodide, is used. The technique is meticulous 
and well described. There are superb illus­
trations of both normal and pathologic 
menisci. The latter are cleverly demonstrated 
by combining high-quality photographs of the 
arthrogram with line drawings to clarify the 
findings and compare them with the patho­
logic specimen. This three-part presentation 
of most types of meniscal tear is valuable, 
both in teaching assessment of the arthrogram 
and in convincing skeptics of its worth.
Although it may be somewhat overpriced, 
this monograph is recommended to any sur­
geon or radiologist beginning to use knee 
arthrography as a diagnostic tool, and to 
those wishing to improve the quality of their 
present films. The technique is particularly 
important and the excellent illustrations will 
be a valuable aid in interpretation.
(Continued on Adv. page 27)
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negative septicemia, or in imminent develop- *
ment of septicemia from serious respiratory or -v 
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staphylococcal infections and its established 
clinical efficacy. „
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infections, GARAMYCIN should be considered when conventional
antimicrobial therapy is inappropriate or when susceptibility
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B. Systemic Infections -  Normal Renal Function
The treatment of systemic infections in patients with normal renal 
function requires a dosage of 3 mg/kg/day in three equally divided 
doses. A course of seven to ten days of treatment will usually 
clear an infection due to a susceptible organism. In patients with 
life-threatening infections, dosages up to 5 mg/kg/day should be 
administered in three or four equally divided doses. This dosage 
should be reduced to 3 mg/kg/day as soon as clinically indicated.
C. Patients with Impaired Renal Function
In patients with diminished renal function or those undergoing 
intermittant hemodialysis, the dosage has to be adjusted depending 
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For detailed information consult the product monograph or the Schering 
Representative.
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Books Received
Books are acknowledged as received, but 
in some cases reviews will also be made 
in later issues.
An Aid to Clinical Surgery. Peter R. Scott. 324 
pp. Illust. Churchill Livingstone, Edinburgh; 
Longman Canada Limited, Toronto, 1971. $14.50.
Angiography. Techniques and Procedures. 
Joseph E. Whitley and Nancy O’Neil Whitley. 
122 pp. Illust. Warren H. Green, Inc., St. Louis, 
1971. $12.50.
Aspirin, Platelets and Stroke. Background for a 
Clinical Trial. Compiled and edited by William 
S. Fields and William K. Hass. 153 pp. Illust. 
Warren H. Green, Inc., St. Louis, 1971. $10.50.
Atlas of the Histology of Brain Tumors. Klaus 
J. Ziilch. 261 pp. Illust. Springer-Verlag, New 
York, 1971. $22.60.
Les Entretiens de Bichat 1971. Chirurgie. Spe- 
cialites. P.-L. Chigot and A. Beilin. 408 pp. 
Expansion Scientifique Frangaise, Paris, 1971. 
Price not stated.
Fundamental Skills in Surgery. 2nd ed. Thomas 
F. Nealon, Jr. 327 pp. Illust. W. B. Saunders 
Company, Philadelphia; W. B. Saunders Company 
Canada Limited, Toronto, 1971. $12.10.
Nouvelle Pratique Chirurgicale Ulustree. Fasci­
cule IV. Deuxieme Serie. Jean Quenu. 251 pp. 
Illust. Doin, Editeurs, Paris, 1971. Price not 
stated.
Occult Traumatic Lesions of the Cervical 
Vertebrae. Martin S. Abel. 148 pp. Illust. Warren 
H. Green. Inc., St. Louis, 1971. $12.50.
The Orthopaedic Management of Spina Bifida 
Cystica. Malcolm B. Menelaus. 116 pp. Illust. 
E. & S. Livingstone, Edinburgh; Longman 
Canada Limited, Toronto, 1971. $10.75.
Outline of Orthopaedics. 7th ed. John Crawford 
Adams. 476 pp. Illust. Churchill Livingstone, 
Edinburgh; Longman Canada Limited, Toronto, 
1971. $8.00.
Progress in Pediatric Surgery. Volume 2. Edited 
by P. P. Rickham, W. Ch. Hecker and J. Prevot. 
178 pp. Illust. University Park Press, Baltimore, 
1971. $12.50.
Scoliosis and Growth. Proceedings of a Third 
Symposium held at The Institute of Diseases of 
the Chest, Brompton Hospital, London, on 13th 
November 1970. Edited by P. A. Zorab. 154 pp. 
Illust. Churchill Livingstone, Edinburgh; Long­
man Canada Limited, Toronto, 1971. $14.50.
Selected Aspects of Skin Cancer. Proceedings 
of the 16th Clinical Conference, November 6, 
1970, Ottawa Civic Hospital and Ottawa General 
Hospital. Edited by M. Hummell and J. O. 
Godden. 135 pp. Illust. Ontario Cancer Treatment 
and Research Foundation, Toronto, 1971. Free.
ROYAL VICTORIA HOSPITAL
PROBLEMS IN 
GENERAL SURGERY
APRIL 5, 6, 7, 1972
This C o u r se  is d e s i g n e d  for the s u r ­
ge o n  in active practice. Se ss ions  w il l  
include gene ra l  su rge ry ,  c o m m o n  
p e r ip he ra l  v a s c u la r  s u rg e ry  a n d  c o v ­
e ra g e  o f  pre a n d  post-ope rat ive  care, 
l e a c h in g  m ethods to be utilized a re  
w a r d  rounds,  ca se  presentat ion, o p e r ­
ative  clinics, s e m in a r s  a n d  lectures. 
Recent a d v a n c e s  w il l  be e m p h a s ize d .  
En ro lm ent  is l im ited to forty-five.
FEE: $ 1 0 0 . 0 0
For further information, write to:
The Secretary, 
Post-Graduate Board,
Royal Victoria Hospital, 
Montreal 112, Quebec.
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SHOCK. A Physiologic Basis for Treatment. Alan 
P. Thai, E . B. Brown, Jr., Arlo S. Hermreck 
and Hugh H. Bell. 304 pp. Illust. Year Book 
Medical Publishers, Inc., Chicago, 1971. $15.25.
A. P. Thai, a surgeon, E. B. Brown, a physi­
ologist, H. H. Bell, a cardiologist and A. S. 
Hermreck, a surgeon, accomplish their mis­
sion in establishing a physiologic basis for the 
treatment of shock.
The concept of shock as a response of the 
body to life-threatening adverse stimuli is 
nicely developed in a historical section, 
further elaborated in a section on pathophysi­
ology and finally applied very practically in 
the section on treatment.
This text is much more comprehensive than 
previous texts on the subject and has a con­
stant clinical focus.
The systemic response to shock is particu­
larly complete and includes a detailed con­
sideration of the coagulation and antifibrin 
mechanisms. The lung, of great importance in 
shock, rightly occupies 50 of the 300 pages of 
this text. However, one would like to see more 
than one-half page on the liver. Newer con­
cepts of the regional distribution of ventila­
tion and perfusion and the ventilation-to-per- 
fusion ratio are clearly presented. Case presen-
(Continued on Adv. page 28)
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tations are used effectively throughout the 
text.
Much of the content of this volume can be 
found in a standard textbook of physiology but 
these familiar concepts, here related to the 
specific problem of the patient in shock, en­
hance our understanding of both the physi­
ology and the clinical problem.
The reader might summarize his impression 
of this text as the applied physiology of the 
acutely ill patient. The publication will be of 
interest to surgeons, internists and indeed all 
who might be required to treat a patient 
in shock.
SURGICAL TECHNIQUES. Herbert Haxton.
199 pp. Illust. John Wright & Sons Ltd., Bristol;
The Macmillan Company of Canada Limited,
Toronto, 1970. $7.95.
This text is of limited usefulness in that it 
records the views of one surgeon and how he 
performs his duties. There is no bibliography, 
although frequent references are made to the 
work of others and their techniques.
This book is not recommended to students 
and house staff because it presents many con­
troversial areas which only the experienced 
surgeon can evaluate.
THIRD NATIONAL WORKSHOP IN 
SCIENTIFIC WRITING
The Division of Postgraduate Medical 
Education of the Faculty of Medicine, 
University of Toronto and the Hospital for 
Sick Children, Toronto, will present the 
Third National Workshop in Scientific 
Writing from March 27-29, 1972.
The workshop will cover the following: 
Writing for Scientific and Medical Journals, 
The Case Report, How to Develop Effec­
tive Tables and Graphs, and Planning a 
“How to” Movie.
The registration is limited to 24 and the 
closing date is January 20, 1972. The fee 
for the course is $100.00. Participants will 
receive their course assignments at the time 
of registration. Further information may 
be obtained from: The Director, Division 
of Postgraduate Medical Education, Faculty 
of Medicine, University of Toronto, Toronto 
5, Ontario.
BLOOD 
FLOW ?
f o r  c lin ic a l 
a p p l ic a t io n s  I
• Designed for clinical O R. 
or cath lab use
• Easily applied handle- 
type probe
• Patient safety assured 
through isolation circuitry
• Simple to operate - 
minimum controls - direct 
meter readout in milliliters 
per minute
BLI
Biotronex Laboratory has eliminated 
the guesswork in evaluating the effective­
ness o f an aorto-coronary vein bypass.
The BL-603 Clinical Blood Flowmeter 
provides a simple, yet effective method 
o f determining graft patency prior to 
surgical closure.
The BL-603 is no t a new instrument; 
i t  is simply an extension o f a device 
which has been thoroughly proven in 
hundreds o f research applications 
throughout the world. I t  is depend­
able; designed to highest safety 
standards; simple in operation; precise 
in measurement - a complement to 
modern day cardio vascular surgery.
Biotronex Laboratory, Inc.
9153 Brookville Road Silver Spring, Maryland 20910 Phone: 301/588-6400
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TWO PROGRAMS FOR SURGEONS
Two programs for surgeons, one on 
trauma and the other on controversial 
areas in surgery, will he presented by 
U.C.L.A. Extension’s Continuing Educa­
tion in Health Sciences and the U.C.L.A. 
School of Medicine in March 1972, at the 
El Mirador Hotel in Palm Springs, Cali­
fornia.
The first, “A Multidiscipline Symposium 
Workshop for Physicians on Management 
of Trauma will be held from March 22- 
25. Among the topics for discussion will 
be ‘ The Surgeon in the Emergency Depart­
ment; Pitfalls and Progress with Central 
Venous Catheterization”, “Current Con­
cepts of Hypovolemic Shock”, “Principles 
in Management of Pelvic and Extremity 
Fractures”, “Bleeding and Clotting Prob­
lems with Massive Trauma” and “Respira­
tory Insufficiency Syndrome”. Other ses­
sions will deal with “Penetrating Wounds 
of the Thoracic Inlet”, “Cardiac Wounds”, 
“The Role of Angiography in Evaluating 
Abdominal Injuries”, “Controversies in the 
Management of Hepatic Injuries” and “The 
Diagnosis of Hemoperitoneum by Lavage”.
The second, “The Ninth Annual U.C.L.A. 
Seminar on Controversial Areas in Surgery”, 
will be held from March 25-29 and will 
present discussion at a level of interest to 
the well-trained surgeon.
Topics will include “Cancer and Im­
munology”, “Breast Lesions: Lobular, Can­
cer and Management of Early Stage I 
Cancer”, “Soft Tissue and Skeletal Sar­
coma”, “Management of Problems of Ile­
ostomy and Colostomy”, “Melanoma”, 
“Cholangiography and Cancer of the Bile 
Duct”, “Pelvic Exenteration for Carcinoma 
of the Cervix or Rectum”, “Liver Scanning 
and Its Role in Surgery”, “Management of 
Pulmonary Metastatic Disease”, “Intra­
venous Therapy for Resuscitation and 
Maintenance” and “Angiography in Trau­
ma: Essential or Investigative?”
The course chairman will he Wiley F. 
Barker, M.D., Professor of Surgery at the 
School of Medicine.
Further information may be obtained 
from the Department of Continuing Educa­
tion in Health Sciences, University Exten­
sion, U.C.L.A., Los Angeles, CA 90024 | 
U.S.A.
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The experts report: “ The importance of the 13- 
Vitamins and Vitamin C in the healing of wounds 
is well known.’’1 . . the traumatic experience 
of an operative procedure may induce relative 
vitamin deficiency states.” 2 And unbalanced 
diets or inadequate food intake before hospitali­
zation and during convalescence can put an 
even greater physiological strain on the patient.
That’s wnere Allbee with C-550 comes in. 
With its more-generous-than-ever amount of 
Vitamin C plus the B Vitamins, it amply fulfills 
increased requirements and compensates for 
deficiencies. So it builds up pre-operative pa­
tients and helps speed post-operative recovery.
Formula:
Thiamine mononitrate (Bi), 15 
mg.; Riboflavin (B2), 10 mg.; Py- 
ridoxine hydrochloride (§6), 5 
mg.; Niacinamide, 50 mg.; Cal­
cium d-pantothenate,10 mg.; 
Ascorbic acid (C), 550 mg. 
Available at pharmacies in bot­
tles of 30, 100 and 500 on your 
prescription or recommendation.
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